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ABSTRACT 
_______________________________________________________________ 
A tropical shrub from Euphorbiaceae (Juss.) family, namely Acalypha 
wilkesiana var. macafeana hort. was investigated for its antioxidant and 
antibacterial properties. The antioxidant properties were assayed by Ferric 
Reducing Antioxidant Power (FRAP) assay, 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) UDGLFDOVFDYHQJLQJDVVD\DQGȕ-carotene bleaching assay. Assessment 
of its antibacterial properties was conducted with pour plate disc diffusion 
assay and dilution methods. The plant was collected, dried, grinded and soaked 
continuously in four different solvent starting from non-polar to polar solvent: 
hexane, ethyl acetate, ethanol and water. The crude extracts were concentrated 
under pressure and kept in -20 °C prior to investigation. 
The ethanol extract of A. wilkesiana var. macafeana hort. exhibited good 
antioxidant and antibacterial activities with results more potent than the 
standards used. To further locate the bioactive constituents of the plant, we 
fractionated the ethanol extract leading to five fractions, namely F1, F2, F3, F4 
and F5. Both antioxidant and antibacterial assays were conducted upon all the 
five fractions. Results showed profound activity from F5 of both antioxidant 
and antibacterial properties which warrants further investigation. 
To shed light on the active constituents of F5, identification was done with 
high performance liquid chromatography (HPLC), liquid chromatography 
mass spectrometry (LCMS) and nuclear magnetic resonance (NMR). 
Separation was obtained with reversed phase HPLC which showed one major 
compound and 6 minor compounds. The major compound was collected with a 
fraction collector and identified as geraniin via interpretation and comparison 
of its NMR shifts, while the other 3 compounds were identified by 
fragmentations of LC-MS. The compounds identified are ȕ-glucogallin, 
potentillin and sanguiin H-6. All identified compounds are ellagitannins, 
except for ȕ-glucogallin which is a gallotannin. 
The in vitro cell-based assay was performed to HepG2 cells to assess the 
ability of antioxidants like ellagitannins to protect cells against oxidative 
insults, and F5 was observed to be able to protect cells against cell death 
induced by t-BHP insults in a dose-dependent manner. F5 was also found non-
toxic in the concentration needed to protect the cells, which is 100 µg/mL. 
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We then explored the synergistic property of the tannin fraction, F5 with 
commercial antibiotics and observed F5 and ampicillin inhibit the growth of 
Staphylococcus aureus synergistically. Field Emission Scanning Electron 
Microscopy (FESEM) analysis was able to demonstrate that the bactericidal 
mechanism of F5 involves cell wall lysis as the result illustrates indentation of 
the cell surface and some showed total collapse of the cells. To explore its 
ability to be formulated and used as a topical agent for treating bacterial 
infections, a preliminary formulation was made incorporating F5, and 
formulated with 3 different bases. The formulation made with the paraffin base 
was observed able to exert the antibacterial property of F5 against 
Staphylococcus aureus in the in-vitro assay. In vivo animal study on guinea 
pigs with an incised cut infected with Staphylococcus aureus and treated with 
the formulation showed that the closure and healing of the wound was faster 
than Burnol®. 
 
Our results indicate possible use of ellagitannins from A. wilkesiana var. 
macafeana hort. with ampicillin to treat Staphylococcus aureus infections as it 
is bactericidal via a mechanism involving cell lysis. It also illustrates the 
possibility to be used as a topical wound healing agent with respect to its 
antibacterial and antioxidant properties. Ellagitannins from A. wilkesiana var. 
macafeana hort. can be viewed as a possible bactericidal agent that can 
contribute to the development of topical antibacterial drug or cosmetics in 
tropical countries. 
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CHAPTER 1 
INTRODUCTION 
_______________________________________________________________ 
 
1.1 General 
 
People have been using plants for healing since centuries ago, as parts of 
powders, decoctions, or potions and herbal drinks. The ethnobotanical study 
leads researches to explore the medicinal plants used by the natives to 
understand how it works, improve the preparations used and finding a standard 
remedy. The research then extends to fingerprinting the plant extracts, 
identifying the bioactive secondary metabolites substances in the plants, 
knowing their relative contribution to the effects of the extracts and identifying 
toxicological doses of the extracts. The earliest isolation of an active 
compound from plants would be the isolation of morphine from Papaver 
somniferum L. (opium) in the early 19th century (Kinghorn 2001; Balunas & 
Kinghorn 2005). Other isolations from medicinal plants that have been 
discovered in the earlier years were cocaine from Erythroxylum coca Lam., 
codeine from Papaver somniferum L., digitoxin from Digitalis sp., and quinine 
from Chincona sp. which some are still in use until now (Newman et al., 2000; 
Butler 2004). Importance of natural products are seen by scientists in most 
health related and medicine aspects from as simple as ageing to epilepsy, from 
2 
obesity to cardiovascular diseases, from healthy lifestyle to treatment of 
diabetes. All portrays the significance of natural products as a source of 
nutrition to human wellness. 
 
Research on chemical and biological properties of natural products over the 
past two centuries has resulted in the discovery of many drugs for the treatment 
of human diseases. More than 50% of all the drugs currently in use are of 
natural product origin (Balandrin 1993). Higher plants have been the source of 
medical agents since earliest time and continue to play a dominant role in the 
health care industry until now (Farnsworth 1985). Secondary metabolites are 
the compounds responsible in plants bioactive properties. Biosynthetic 
pathways are responsible for the occurrence of both the primary metabolites 
and secondary metabolites in plants. Primary metabolites are any intermediate 
in, or product of primary metabolism, which are metabolic activities that are 
common in most living cells and are necessary for growth, maintenance and 
survival (Attwood & Cammack 2006) for example carbohydrates and protein. 
Secondary metabolites are traditionally defined as substances that appear to 
have no explicit role in the internal economy of the organism that produces it 
(Williams et al., 1989) and will be considered as a bioactive compound when it 
exerts biological effect on other organism. Others define secondary metabolites 
as a compound whose biosynthesis is restricted to selected plant groups and are 
3 
synthesized to address specific needs, for example floral scent and pigments 
from flowers attract pollinators and enhance fertilization (Pichersky & Gang 
2000).   
 
Identifying the bioactive secondary metabolites in traditionally used plants is 
becoming an interest to more and more researchers worldwide. The research is 
expanding as substantial numbers of structures are being identified from plants. 
These compounds are then screened for their biological activity to assess its 
bioactive properties. Chemical constituents from plants can be classified based 
on their biosynthetic origins, where they are divided into 3 major group i.e., 
terpenoids which are derived from isopentyldiphosphate (IPP), alkaloids which 
are biosynthesized from amino acids and contain nitrogen and phenolic 
compounds which are formed by either the shikimic acid pathway or the 
malonate/acetate pathway (Croteau et al., 2000). 
 
Experimentation with single constituent provides better understanding of the 
mechanisms involved in a traditionally used plant or herbs. Without identifying 
its active compound, the mechanism of action of the plant or herb cannot be 
determined. In explaining the phytochemical basis of herbal medicines, 
herbalists are assessing plant properties in a holistic approach where the 
properties are given by the sum of totality of its constituents (Penggelly 2005). 
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Phytochemists are actively identifying and isolating active constituents from 
the plants and assessing their properties as a single constituent. Knowledge of 
individual constituents is essential to understand pharmacological activity, 
pharmacokinetics, potential toxicology and interactions with pharmaceutical 
drugs. 
 
Scientists embarked on antibiotics in the 19th century, with sulfa drugs in the 
¶V 'UHZV  DQG SHQLFLOOLQ LQ WKH ¶V /igon 2004). Since their 
introduction, antibiotics have allowed the treatment of bacterial infections and 
have saved many millions of lives (Fauci & Morens 2012). The discovery of 
penicillin by Fleming in 1928, as reported in the British Medical Literature was 
WKHEHJLQQLQJRIWKHµ*ROGHQDJHRIDQWLELRWLFV¶7KHVWUXFWXUHZDVQHZWRWKH
chemistry world when it was first elucidated, but soon enough everything 
about it was revealed as research on penicillin continues. Penicillin was then 
semi-synthesized to derive the structure as resistance to the antibiotic was 
observed almost just after it was released and was used. The bacterium almost 
LPPHGLDWHO\ SURGXFHG SURWHFWLYH HQ]\PHV DQG SURGXFHV ȕ-lactamases that 
were able to degrade penicillin. The search for antibacterials continues, as 
UHVLVWDQFHEHFRPHDPRUHDODUPLQJSUREOHPDQGµ0RWKHU1DWXUH¶VWLOOSURYHV
to become the most important source for finding new compounds for this 
purpose (Newman et al., 2000).  
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All antibiotics share an inherent weakness as the bacteria they target almost 
continuously develop new mechanisms of resistance (Davies & Davies 2010) 
on account of inadequate posology in hospital settings and communities 
(Buffet-Bataillon et al., 2012). Therefore, there is an obvious need to 
counteract bacterial resistance. One way to fight bacterial resistance is the use 
of multi component therapy. Indeed, combination between two or more 
antibiotics or natural products with antibiotics broadens bacterial targets or 
increase action on the same target (Wright 2012). Berdy et al. (2005) reported 
the presence of 200,000 bioactive natural products; therefore there is the 
exciting possibility to use natural products to maintain or boost the clinical 
effects of antibiotics via synergistic studies (Wiart 2012).  
 
Important physiological functions involves normal cell metabolism. Normal 
metabolism produces oxidant by products (reactive oxygen species, ROS) to 
which causes damage to DNA, protein, and lipid which is the major 
contributor to aging and degenerative diseases (Ames et al., 1993). 
Endogenous sources of ROS would be from the perixosomes, mitochondria, 
cell activation and cytochrome P450 metabolism (Jatawa et al., 2012). Besides 
the endogenous sources of oxidants from metabolism, exogenous sources 
would also increase the load. Exogenous sources may come from oxides of 
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nitrogen in smoke, ultraviolet light, ionization radiation, environmental toxins 
and from metals and ions (Noh & Ha 2011). 
 
Excess ROS leads to oxidative stress which is defined as the imbalance 
between antioxidants and oxidants in favour of the oxidants (Dudonne et al., 
2009). The production of ROS and free radicals are normally accommodated 
by an elaborate endogenous antioxidant system. However, due to 
environmental, lifestyle, and other emerging factors, the elaborate system is 
abortive and causes access of the radicals (Lima et al., 2007). Oxidative stress 
causes stress condition at cellular level thus, causing structural damage to the 
DNA, membrane, lipids, and proteins. 
 
In fact, oxidative stress has been recognized to be involved in the diagnosis of 
several chronic diseases including cardiovascular diseases, cancer, diabetes, 
arthritis, nephrophathy and the list continues on (Jatawa et al., 2012; Ames et 
al., 1993). It is also the major cause for minor illness, fatigue, infertility and 
aging. Studies have recognized the involvement of ROS in the etiology of liver 
diseases such as hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma 
(Vitaglione et al., 2005). Liver is a vital organ which plays a major role in 
metabolism including glycogen storage, plasma protein synthesis, hormone 
production and detoxification of the body. Consequently, mechanisms of 
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protection of liver are of high interest, and natural antioxidants as therapeutic 
agents are soughed to counteract oxidative stress generally, and liver damage 
specifically. 
 
As part of an ongoing study to identify antioxidants and antibacterial from 
medicinal plants (Wijaya et al., 2011a; Wijaya et al., 2011b), we have 
previously isolated flavanoid glucosides, flavanones and pyrrolizidine 
alkaloids. One of the largest group of flowering plants is the Euphorbiaceae 
with 300 genera and 7500 species (Wiart 2006) which provides numerous 
plants used for treatment of inflammatory conditions, wounds and bacterial 
infections. For example, Acalypha racemosa Wall. ex Baill. and Acalypha 
indica Linn. are used to treat liver disorders and hepatic dysfunstion on 
probable account of its antioxidant properties (Iniaghe et al., 2008; Matthew et 
al., 2011). Other Acalypha species are also studied for their antioxidant and 
cytoprotective properties (Kavitha et al., 2009; Joy et al., 2010; Onocha et al., 
2011a; Onocha et al., 2011b).  An unidentified variety of Acalypha wilkesiana 
seeds are used as with a mixture of other herbs as treatment for breast cancer 
and inflammation (Bussing et al., 1999) and are found to be inducing apoptosis 
in U87MG (human glioma cells) and A549 (human lung carcinoma cells) by 
causing single stranded and double stranded DNA breaks (Lim et al., 2011).  
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Medicinal plant members of the family Euphorbiaceae impart anti-infective 
and wound healing properties (Wiart 2004). For instance, A bark extract of 
Jatropha curcas L. (Euphorbiaceae) which is traditionally used to treat 
diarrhoea and dysentery, inhibited the growth of Bacillus subtilis, Sarcina 
lutea and Salmonella thyphi with inhibition zone diameters of 18.0 ± 1.0 mm, 
17.0 ± 0.5 mm and 17.0 ± 0.2 mm, respectively at a dose of 3 mg/disc (Gupta 
et al., 2011). Sapium sebiferum L. (Euphorbiaceae) is also used traditionally to 
treat diarrhoea, exhibited antimicrobial activity against Gram-negative 
Escherichia coli at a dose of 1.5 mg/mL (Chaudhary et al., 2011).  An extract 
of Acalypha indica L. (Euphorbiaceae) inhibited Gram-positive bacteria and 
used traditionally used for bronchitis, pneumonia and asthma (Somchit et al., 
2010). Croton hirtus /¶+pUDQGEuphorbia hirta L. (Euphorbiaceae) exhibited 
antibacterial activity against Bacillus cereus, Bacillus subtilis and 
Staphylococcus aureus (Wiart et al., 2004).  
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1.2 Aim and objectives of the study 
 
The overall aim of this study was to identify active compound(s) from 
Acalypha wilkesiana var. macafeana hort. that elicits antioxidant, 
cytoprotective and antibacterial properties and examine their ability to be used 
in a topical formulation. 
 
Objectives of the study are: 
1. To collect A. wilkesiana var. macafeana hort. and extract its 
constituents with sequential maceration. 
2. To screen the antioxidant properties of the extracts with ferric reducing 
antioxidant potential (FRAP) assay, DPPH radical scavenging assay 
DQGȕ-carotene bleaching assay.  
3. To evaluate the cytotoxicity and cytoprotective concentrations of the 
active extract. 
4. To screen the antibacterial properties of the extracts with the pour plate 
disc diffusion assay. 
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5. To determine the minimum inhibition concentration (MIC) and 
bactericidal concentration (MBC) of the active extract. 
6. To evaluate the location of the active constituent(s) with fractionation 
by chromatographic means.  
7. To isolate the major active constituent(s) with High Performance 
Liquid Chromatography (HPLC) and identify by spectroscopic means 
which includes Liquid Chromatography-Mass Spectrometry (LC-MS) 
and Nuclear Magnetic Resonance (NMR). 
8. To produce a topical formulation from the active constituent(s) and test 
it for bacterial infection and wound healing properties. 
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CHAPTER 2 
LITERATURE REVIEW 
_______________________________________________________________ 
 
2.1 Natural Product Approach in Drug Discovery 
 
Natural products were the first ever cure available to mankind in history as no 
synthetic medicines were yet discovered then (Ganesan 2008). Thus, plant 
natural product approach in drug discovery brings great importance with two 
premises; natural products interrogate a different area of chemical space than 
synthetic compounds, and natural products are amenable to further 
development (Ganesan 2008). Over the past few years, pharmaceutical 
companies have scaled down their funding and interests to natural products due 
to the drawbacks that are encountered in natural product research, which 
includes time consuming process of screening, isolation and structure 
elucidation of the compounds and challenging compound development (Butler 
2004). 
 
However recently, a renewed interest has flaunted as the challenges of natural 
product approach to drug discovery is overcome by improvement in 
technology, hence the continuous effort in drug discovery from natural 
products until now (Cragg et al., 2012). As to the year 2008, over 100 natural 
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product-derived compounds are currently undergoing clinical trials and 100 
more are in preclinical development (Harvey 2008) of which anticancer and 
anti-infectives leads the list. Until now, still more natural product derived 
compounds serve as basic framework for design and synthesis of drugs (Cragg 
et al., 2012). The immense chemical complexity and diversity of natural 
product from plants represent therefore an important source of drugs. 
Researchers will continue to investigate flowering plants in high biodiversity 
ecological systems like the rainforest of Malaysia.  
 
2.2 Plants in Malaysia 
 
The Malaysian rainforest stores a large number of flowering plant species of 
which have been used by Orang Asli and the Malays as source of food and 
medicine (Wiart 2006). Indeed, about 10, 000 species of flowering plants and 
2000 species of lower plants are available in Peninsular Malaysia, and only 16 
% are claimed to be used traditionally (Latif et al., 1984). Common modes of 
administration of these plants by traditional Malaysians are oral and topical 
and are used as decoctions, infusions, poultices or simply pounded (Ong et al., 
2011). The earliest record on the use of plants as medicine in Malaysia was 
reviewed by Burkill and Haniff (1930), Gimlett and Burkill (1930) and Burkill 
(1966) whereby several of them belongs to the family Euphorbiaceae Juss.  
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2.3 The Family Euphorbiaceae Juss. 
 
The family Euphorbiaceae found by A.L. de Jussieu in 1789, or known as the 
Spurge family is a large family of flowering plants with 300 genera and around 
7500 species which includes trees, shrubs and herbs (Wiart 2006a). Several 
characteristics in identifying species in this family include 3-locular capsules, 
stipules and spikes of tiny flowers (Nelson 1996). The family is divided to 4 
subfamilies which are the Phyllanthoideae (ovules 2 loculus; no latex), 
Euphorbiodeae (ovules 1 per loculus; latex usually present) in which includes 
the Acalypheae, Porantheroideae (ovules 2 per loculus; no latex) and the 
Ricinocarpoideae (ovules 1 per loculus, latex present) (Hickey & King 1988). 
Several members of the family Euphorbiaceae Juss. are used as traditional 
remedies (Table 2.1) (Ong 2006). 
 
2.4 The Genus Acalypha L. 
 
The genus Acalypha was first described by Linnaeus  in 1753. As the third 
largest genus in the family Euphorbiaceae after Euphorbia L. and Croton L., 
Acalypha L. comprises of 450 species. Acalypha species are widespread 
geographically, with greatest diversity in the tropics and sub-tropics (Sagun et 
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al., 2010). As of a review from Sagun et al. (2010), from the 450 species of 
Acalypha, there are 28 species  
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Table 2.1. Plants used traditionally in Malaysia that belong to the Euphorbiaceae Juss. and their claimed medicinal purpose. 
No. Scientific Name Vernacular Names Traditional uses References 
1 Sauropus androgynus (L.) 
Merr. 
³Cekur manis´, ³katok´ 
star gooseberry 
Postpartum relief and cardiovascular 
illness 
Ong 2006; Koh et al., 2009 
2. Phyllanthus emblica L. ³Buah Melaka´, Indian 
gooseberry 
Treatment of fever, headaches, 
migraine 
Burkill 1966; Ong, 2006 
3. Mallotus barbatus Müll. Arg. ³Balik angin´ Treat abscesses and wounds, back and 
joints ache  
Fatan Hamamah et al., 2003; 
Ong 2006 
4. Bridelia insulana Hance. ³Kenidai´ Treat itchness of skin Ong 2006 
5. Macaranga triloba (Thunb.) 
Müll. Arg. 
³Mahang merah´ Treatment of fungal and bacterial 
infections 
Ong 2006; Lim et al., 2009 
6. Aleurites mollucana (L.) Willd. ³Buah keras´, candlenut Treatment of constipations, gonorrhea 
and dysentery 
Ong 2006 
7. Acalypha wilkesiana Müll. 
Arg.  
³Akalifa´-DFRE¶VFRDW
copper plant 
Treatment of hemorrhoids, 
inflammation, skin infections 
Ong 2006 
8. Acalypha hispida Burm. f. ³Ekor kucing´)R[¶VWDLO Treatment of ulser, skin infections, 
asthma and flu 
Ong 2006 
9. Codiaeum variegatum (L.) 
Blume. 
³Pokok SXGGLQJ´ Treatment of syphilis, abscesses, and 
fever 
Ahmad & Holdsworth 2003; 
Ong 2006 
10. Excoecaria cochinchinensis 
Lour. 
³Sambang darah´, Chinese 
croton 
Post partum and menstrual pain relief Ong et al., 1996; Ong 2006 
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recognized in the Malesian region which consists of Peninsular Malaysia, 
Borneo, Papua New Guinea, Indonesia and Philippines. Two species are 
exclusively West Malesian, 20 species are East Malesian, while six other 
species are distributed throughout the region (Sagun et al., 2010).  
 
2.4.1 Botanical Features 
The genus Acalypha L. consists of mainly trees and shrubs, which provides 
economical, ecological and ornamental plants (Govaerts et al., 2000). The 
description and taxonomy of the genus Acalypha L. has been attempted by 
various authors such as Levin (1998), Qin et al. (2006), Sagun and Levin 
(2007) and latest by Sagun et al. (2010). The species are either monoecious or 
dioceious.  
 
The leaves are alternate, stipulate and serrate (Figure 2.1). The staminate 
flowers present 4 valvate sepals, 4 to 8 stamens and vermiform anthers. The 
pistillate flowers are bracteate with 3, 4 or 5 sepals and 2 to 3 carpels with one 
ovule per carpel (Figure 2.3). Many species of Acalypha L. share the 
characteristic of pistillate flowers and fruits. Majority of the species have in 
fruit accrescent (grows in size after flowering) pistillate bracts that vary in 
number and shape of the lobes (Figure 2.2). The fruits are bilocular or 
trilocular capsules (Figure 2.4). Stipules morphology vary from linear or 
needle like to broad ovate shape (Figure 2.5). 
 17 
 
 
Figure 2.1. Leaf morphology of Acalypha L. sp. a1) A. amentaceae Roxb. b1) 
Acalypha angatensis Blanco. c1) A. capillipes Mull. Arg. d1) A. cardiophylla 
Merr. f1) A. caturus Blume. h1) A. novoguineensis Warb. (Sagun et al., 2010). 
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Figure 2.2. Pistillate bract morphology of Acalypha L. sp. a) A. amentaceae 
Roxb. b) A. angatensis Blanco. c) A. australis L. d) A. brachystachya Homem. 
(Sagun et al., 2010). 
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Figure 2.3. Allomorphic pistillate flowers of Acalypha L. sp. a) A. antagensis 
Blanco. b) A. bracystachya Homem. c) A. indica L. d) A. lanceolata Willd. 
(Sagun et al., 2010). 
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Figure 2.4. Fruit morphology of Acalypha L. sp. a) A. cardiophylla Merr. b) A. 
cinnamomifolia Pax & K.Hoffm. c) A. caturus Blume. d) A. siamensis Oliv ex 
Gage. (Sagun et al., 2010). 
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Figure 2.5. Stipule morphology of Acalypha L. sp. a) A. amentaceae Roxb. b) 
A. angatensis Blanco. c) A. cardiophylla Merr. d) A. hellwigii Warb. e) A. 
longispica Warb. (Sagun et al., 2010). 
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2.4.2 Pharmacological Properties 
Several line of evidences points to the fact that members of the genus Acalypha 
L. are pharmacologically active (Solomon et al., 2005; Olundunmoye et al., 
2006; Kambara et al., 2006; Mothana et al., 2008; Canales et al., 2011). 
Antibacterial and antifungal properties have been observed from A. indica L., 
A. fruticosa Forssk., A. communis Müll. Arg., A. siamensis Gagnep., A. 
monostachya Cav., A. hispida Burm. f. and A. wilkesiana Müll. Arg. (Solomon 
et al., 2005; Olundunmoye et al., 2006; Kambara et al., 2006; Mothana et al., 
2008; Canales et al., 2011). Antioxidant and protective properties were elicited 
by A. indica L., A. fruticosa Forssk., and A. racemosa Wall. ex Baill. (Badami 
et al., 2007; Iniaghe et al., 2008; Mothana et al., 2008). Extracts of A. 
wilkesiana Müll. Arg., A. alopecuroidea Jacq. and A. australis L. displayed 
anti-cancer properties against different cell lines in vitro (Madlener et al., 
2010; Shin et al., 2012).  
 
In vivo studies evidenced the anti-diabetic properties from A. wilkesiana Müll. 
Arg. and Acalypha indica L. (Ikewuchi et al., 2011; Itankar et al., 2011) but the 
active constituents are yet unknown. A recent study from Quds et al. (2012) 
showed antiemetic property of A. ornata Hochst. ex A. Rich., A. wilkesiana 
Müll. Arg. and A. fimbriata Schumach. & Thonn.  
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2.4.3 Chemical properties 
Oddly enough, the genus Acalypha L. has not drawn much attention to trace its 
active constituents, despite the fact that significant studies on the 
pharmacological properties have been undertaken. There is a dearth of 
information about the phytochemistry of this genus. Preliminary studies 
resulted in the identification of flavonoids, terpenes and tannins. Indeed, 
identification of compounds from A. hispida Burm. f. from two studies have 
isolated ellagitannins (geraniin, mallotusin, phyllantusin C, euphorbin A and 
B, acalyphidin M1, M2 and D1, furosin and repnadinin A) (Figure 2.6) and 
flavonoids (quercetin-3-O-rutinoside and kaemferol-3-O-rutinoside) from 
Acalypha hispida Burm. f. (Amakura et al., 1999; Adesina et al., 2000) (Figure 
2.7). 
 
 24 
 
 
Figure 2.6 (a). Tannins isolated from Acalypha sp. - Acalyphidin M1 
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Figure 2.6 (b). Tannins isolated from Acalypha sp. - Euphorbin A 
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Figure 2.6 (c). Tannins isolated from Acalypha sp. - Phyllanthusiin C 
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Figure 2.6 (d). Tannins isolated from Acalypha sp. -  Mallotusinin  
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Figure 2.6 (e). Tannins isolated from Acalypha sp. - Repandinin A  
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Figure 2.7 (a). Flavonoids, glycosides and terpenes from Acalypha sp. -  
Kaempherol-3-O-rutinoside 
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Figure 2.7 (b). Flavonoids, glycosides and terpenes from Acalypha sp. - 
Quercetin-3-O-rutinoside 
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Figure 2.7 (c). Flavonoids, glycosides and terpenes from Acalypha sp. -  
Acalyphin 
 
  
32 
 
 
 
Figure 2.7 (d). Flavonoids, glycosides and terpenes from Acalypha sp. - Acalyphaser A 
\
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Acalyphin, a cyanogenic glucoside, was isolated by Nahrstedt et al. (1982) 
from A. indica L., and 4 flavonoids were identified from the same plant in 
2006 (Nahrstedt et al., 2006). The tetraterpene, Acalyphaser A, was isolated 
from Malaysian A. siamensis Oliv. ex Gage. (Kambara et al., 2006). Tannins 
(geraniin, corilagin and gallic acid) were elucidated from A wilkesiana 0܄ll. 
Arg. and are claimed to be responsible for its antimicrobial property (Adesina 
et al., 2000). Besides the isolations of the compounds, there are many 
researchers that opt to only identify the presence of the phytochemical 
constituents by executing phytochemical screenings on the extracts. The 
phytochemical screenings also coincides with the isolation, which leads to 
terpenoids, flavonoids and tannins being the major compounds in Acalypha 
species (Mothana et al., 2008). 
 
2.5 Acalypha wilkesiana var. macafeana hort. 
 
The name Acalypha wilkesiana originated from Greek, a, which means 
³without´ and kalyphos, which means ³cover´. The plant was named after 
Admiral Charles Wilkes, a 19th century American naval officer and explorer in 
the South Pacific (Wiart 2006). Common names are beef steak plant, -DFRE¶V
coat, copper plant or fire dragon. Locally in Malaysia, it is called ³Akalifa´ 
(Ong 2006). 
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2.5.1 Botanical Features 
A. wilkesiana var. macafeana hort. (Figure 2.8) is a tropical bush with 
variegated copper-red leaves which are ovate to elliptic shaped. Its leaves are 
10 -20 centimeters long and arranged in simple and spiral arrangement. This 
plant can grow up to 4 meters high and is cultivated in Malaysia and all over 
the Asia-Pacific region as an ornamental plant. The inflorescences are spikes 
bearing male and female flowers at the base. The flowers are apetalous and 
without nectar disc. Its flowering season is between February to December 
(Sagun et al., 2010). 
 
2.5.2 Pharmacological Properties 
According to Ong (2006), the leaves are traditionally used in Malaysia in 
treatments for inflammation, headache, fever and flu, whereas its roots are 
boiled to wash haemorrhoids. A beverage consisting of about 60 g of the 
leaves are boiled in goats milk is drunk to lower blood temperature, treat fever, 
relieve cough and heal pimples. It is also said that 10 g of the leaves boiled 
with sugar is used to treat thrombocytopenic purpura and allergic purpura 
which are skin disorders caused by bleeding underneath the skin (Wiart 2006).  
It is also used in other tropical countries to traditionally treat other diseases 
such as Pityriasis versicolor, tinea and other dermatological disorders, malaria 
DQGEUHDVWWXPRUV%܄ssing et al., 1999; Oyelami et al., 2003; Akinyemi et al., 
2005).
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Figure 2.8. Morphology of A. wilkesiana a) Leaf morphology b) Details of the 
leaf morphology showing the indumentum c) Pistillate bract morphology 
(Sagun et al., 2010). 
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In West Africa, the plant is used in the form of decoction, infusion or tincture. 
The leaves are rubbed in between palms and the juice is smeared on the 
affected part of a patient for treatment of Pityriasis versicolor and other skin 
infections. Grinded leaves may be used as soap to wash affected parts of the 
skin (Adesina et al., 1980).   
 
2.5.3 Research Commenced on Acalypha wilkesiana 
To date, the pharmacological properties of A. wilkesiana var. macafeana hort. 
are unknown, however, some evidence have been produced on A. wilkesiana 
0܄ll Arg. In West Africa, research on A. wilkesiana 0܄ll Arg. started as early 
as 1980 with Adesina and colleagues from University of Ile-Ife, Nigeria with 
the phytochemical and biological examination of the leaves, which observed a 
broad-spectrum inhibition of Gram-positive and Gram-negative organisms 
with the well diffusion method. 
 
Indeed, water and ethanol extracts of this plant showed antimicrobial 
properties with standard and local strains of Gram-positive bacteria 
Staphylococcus aureus and fungi Trichophyton rubrum, Trichopyhton 
mentagrophytes, Candida albicans 
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Figure 2.9 (a) Acalypha wilkesiana var. macafeana hort. shrub 
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Figure 2.9 (b). Acalypha wilkesiana var. macafeana hort. leaf morphology. 
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and Aspergillus flavus further proving the antiseptic property of this plant 
(Alade & Irobi 1993). A study in vitro on Methicillin Resistant Staphylococcus 
aureus (MRSA) reported good antibacterial activity against MRSA (Akinyemi 
et al., 2005).  
 
2.5.4 Phytochemical Studies and Isolated Constituents from Acalypha 
wilkesiana  
Adesina et al. (2000) found 3 tannins in the leaves of A. wilkesiana which are 
gallic acid, corilagin and geraniin (Figure 2.10), all are said to be responsible 
for the antimicrobial properties of this plant. Phytochemical screening shows 
abundance of tannins, saponins and alkaloids in A. wilkesiana 0܄ll. Arg and 
absence of anthraquinones (Soladoye et al., 2008). A comparative 
phytochemical study on 2 varieties of A. wilkesiana Mull Arg. by Oladunmoye 
et al. (2006) showed presence of tannins, saponin, anthraquinone and cardiac 
glycoside in both varieties studied. Other screenings also showed similar 
results of compounds detected (Akinyemi et al., 2005). 
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(a) 
 
 
(b) 
 
Figure 2.10 (a). Tannins identified from A. wilkesiana M܄ll Arg. (a) Gallic 
acid, (b) corilagin 
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(c) 
 
Figure 2.10 (b). Tannins identified from A. wilkesiana 0܄ll Arg. (c) Geraniin 
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2.6 Antibacterial Agents from Flowering Plants 
 
2.6.1 Infectious Diseases 
The World Health Organization (WHO) defined infectious diseases as diseases 
caused by pathogenic microorganisms such as bacteria, fungi, parasites or 
viruses, which can be spread to another individual either directly or indirectly 
(Finlay 2010). The latest statistic report from WHO shows 26.8 % of deaths 
are due to infectious diseases and infections in South East Asia region. 
Infectious diseases are the second leading cause of death worldwide, and 
bacteria which are increasingly resistant to antibiotics are well represented 
among the killers (Finlay 2010).  
 
The European Centre for Disease Prevention and Control (ECDC) and the 
Centre for Disease Control and Prevention (CDC), focus discussions to 
infections by Gram-positive Staphylococcus aureus, Enterococcus sp., 
Enterobacteriaceae (other than Shigella and Salmonella), and Gram-negative 
Pseudomonas aeruginosa and Acinetobacter sp. due to their significant 
epidemiologies and emerging resistances within the healthcare system 
(Magiorakos et al., 2012). These pathogenic bacterium evolves to gain 
resistance against current antibiotics. According to Asian Network for 
Surveillance of Resistant Pathogens (ANSORP), MRSA infections accounts 
for 25.5 % of community-associated infections and 67.4 % of healthcare-
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associated infections in Asian countries (Song et al., 2011). In Malaysia, the 
cause of 10 hospital admissions per 1000 admissions is due to Methicillin 
resistant Staphylococcus aureus (MRSA) infections (Al-Talib et al., 2010).  
 
Resistance in bacteria has made the search for new antibiotics more needed 
than ever (Gibbons 2008). Infections caused by resistant strain bacteria 
represent a major public health burden in terms of morbidity, mortality, 
increased expenditure on patient management and infection control measures 
(Woodford & Livermore 2009). Bacteria are capable of resisting the action of 
antibiotics via activation of latent mobile genetic elements, mutagenesis of its 
own DNA and physical exchange of genetic material with another organism 
(Dwyer et al., 2009). Worldwide emergence of resistant bacteria has been 
associated with misuse and increasing use of antibiotics in the healthcare 
settings and the lack of specific drugs for treating patients (Buffet-Bataillon et 
al., 2012). 
 
2.6.2 Infections Due to Staphylococcus aureus 
Staphylococcus aureus, a Gram-positive cocci named from Greek with the 
PHDQLQJµJROGHQJUDSH-FOXVWHUEHUU\¶ is a bacterium which causes a multitude 
of diseases either due to direct infection or the productions of toxins (Archer 
1998). Staphylococcus aureus produces toxins which are known as one of the 
virulence factors that contributes to its ability to cause infections which are 
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categorized to groups of pyrogenic toxin superantigens (PTSAgs), exfoliative 
toxins (ETs), leukocidins and other toxins (Verkaik et al., 2010). It is 
frequently found as part of the normal skin flora on the skin and nasal 
passages. Staphylococcus aureus has been recognized as a major cause of 
wound excretions and a major human pathogen.  
 
Staphylococcus aureus has a diverse arsenal of components and products that 
contribute to the pathogenesis of infection, either they act together or alone. 
Generally, the pathogenesis of infections of Staphylococcus aureus has been 
reviewed by Archer (1998) which comprises of five stages which are: 
1) Colonization 
2) Local infection 
3) Systemic dissemination and/or sepsis 
4) Metastatic infection 
5) Toxinosis. 
 
Healthy individuals are colonized by Staphylococcus aureus usually in the 
anterior nares, vaginal and perianal area which are carried without any 
symptoms for weeks or months (Archer 1998). Local abscess results when the 
organism is inoculated into the skin from the site of carriage. The infection can 
either be local or carried into the blood. Once in the blood, the bacteria will 
spread widely to the whole body and septic shock might occur. Dissemination 
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of the organism, without specific therapy, will result to a number of infections 
i.e., endocarditis, septic arthritis or epidural abscess. Finally, if the organism 
does not invade the bloodstream, local or systemic effects of specific toxins 
will occur such as toxic shock syndrome and food borne gastroenteritis (Archer 
1998). 
 
Occurrence of Staphylococcus aureus infection in both hospital and 
community acquired infections increase steadily as treatments have become 
more difficult due to emergence of resistant strains (Voss & Doebbeling 1995). 
In Malaysia, occurrence of Staphylococcus aureus infections follows the same 
trend, as it is the second most common bacterium isolated from blood 
(Ministry of Health 2008). Among the Staphylococcus aureus infections, 26 % 
of the isolates from clinical specimens in 2008 were of Methicillin-resistant 
strains (MRSA) (Ahmad et al., 2010). The first community acquired 
Methicillin resistant Staphylococcus aureus (MRSA) case in Malaysia was 
reported by Shamsudin et al. (2008).  
 
2.6.2.1 Staphylococcal Food Poisoning 
Staphylococcus aureus colonization of food may cause gastroenteritis with 
emesis with or without diarrhea. This condition is called staphylococcal food 
poisoning and results from ingestion of one or more staphylococcal 
enterotoxins (Dinges et al., 2000). Staphylococcal food poisoning is a common 
 46 
cause of food poisoning in the world and the condition usually self resolves 
within 24 to 48 hours of onset.  
 
2.6.2.2 Skin and Soft-tissue Infections 
x Impetigo 
Impetigo is a contagious skin infection caused by Staphylococcus sp. or 
Streptococcus sp. It is more common in children than in adults. There are two 
forms of impetigo; non-bullous impetigo and bullous impetigo. The non-
bullous impetigo is more common and can be caused by either bacteria. Small 
red papules are observed and will eventually evolve to small blisters and 
finally scab over with a characteristic honey coloured crust. In bullous 
impetigo, which is only caused by Staphylococcus sp., the top skin layer 
(epidermis) and the lower skin layer (dermis) separates due to a toxin that is 
produced by Staphylococcus, thus leading to the formation of a blister (termed 
bulla in medicine). These blisters are fragile and contains yellow liquid often 
breaks and leaves red and raw skin. Finally a dark crust will develop (Cole & 
Gazewood 2007).  
 
Mild impetigo can be treated with an antibiotic ointment such as muciprocin. 
More severe impetigo would require oral antibiotics. Common oral antibiotics 
prescribed are penicillins (such as Augmentin) and cephalosporins (such as 
Cephalexin). If treatment with these antibiotics is not effective, an MRSA 
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infection would be suspected and culture tests would be done. MRSA 
infections would need antibiotics such as sulfamethaxozole.    
 
x Scalded Skin Syndrome 
Scalded skin syndrome is an illness characterized by red blistering of the skin 
that is similar with a burn or a scald. Scalded skin syndrome occurs mostly in 
children younger than 5 years old. Antibodies gained against staphylococcal 
exotoxins are usually acquired during childhood, hence less common in older 
children and adults. The illness is caused by the release of two exotoxins which 
are epidermolytic toxin A and B from Staphylococcus aureus. The 
epidermolytic toxins are very tissue and species specific, attacking only certain 
keratinizing epithelia of mice, hamsters, monkeys and human (Elias et al., 
1977).  
 
The epidermolytic toxins released by Staphylococcus aureus causes cleavage 
of the middle layer of the epidermis and ultimately, slippage of the epithelium 
layer upon gentle pressure (Gemmell 1995). Scalded skin syndrome initiates 
from a localized staphylococcal infection accompanied by fever, irritability 
and widespread redness of the skin. Within 24 to 48 hours after onset, fluid 
filled blister will form and will rupture and cause the skin to look like a burn.  
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Treatment of scalded skin syndrome usually requires hospitalization with 
intravenous antibiotics generally necessary. A penicillinase resistant anti-
staphylococcal antibiotic such as flucloxacillin can be used. Recovery is 
usually complete within one week after treatment with the right antibiotic. If 
the illness is left untreated or treatment is unsuccessful, severe infection will 
develop such as sepsis, cellulitis and pneumonia and eventually mortality.  
  
x Acne 
Staphylococcal acne is medically known as staphylococcal folliculitis. It is an 
infection of the hair follicle caused by Staphylococcus aureus which are 
localized on an individual, and infects the surface of the skin when there is a 
break in the skin that occur from shaving, skin friction or rubbing from clothes. 
7KHVHIROOLFXODUOHVLRQVIUHTXHQWO\FRH[LVWHGDWWKHVZHDWSRUHV2¶Brien 1952). 
This condition can be treated with topical application of fusidic acid and oral 
intake of penicillin (Smith 1978).  
 
2.6.2.3 Bacteremia and Pneumonia 
Pneumonia caused by Staphylococcus aureus occurs in about 1 to 10 % of 
community-acquired pneumonia (Gonzalez et al., 1999). Diagnosis of 
pneumonia caused by Staphylococcus aureus is made when there are existing 
symptoms of infection of the lower respiratory tract such as cough, purulent 
expectorant and chest pain, coinciding with the isolation of Staphylococcus 
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aureus. Pneumonia caused by MRSA is the second most frequent infection 
after surgical wound infection and is a major factor associated to mortality 
(Gonzalez et al., 1999). Bacteremia is defined when one or more hemocultures 
are identified positive for this bacterium, accompanied by symptoms of clinical 
sepsis such as chills, fever, skin rash, a drop in blood pressure and very fast 
breathing.  
 
2.6.2.4 Toxic Shock Syndrome 
This illness was brought to attention to the medical world in 1978 by Todd et 
al. who identified toxic shock syndrome as a major systemic illness associated 
with noninvasive Staphylococcus aureus infections in children (Dinges et al., 
2000). The toxic shock syndrome is an acute and fatal illness that is 
characterized by high fever, diffuse erythematous rash, desquamation of the 
skin, hypotension, and involvement of three or more organ systems (Lowy 
1998). ,QWKHHDUO\¶VDQHSLGHPLFRIWKHWR[LFVKRFNV\QGURPHRFFXUUHG
among young women in the United States which were later identified as 
caused by the use of tampons during menstruation (Lowy 1998).  
 
2.6.3 Drugs Available for Treatment of Bacterial Infections 
The discovery of penicillin in 1928 by Fleming led to the discovery of many 
more antibiotics that either successfully make through clinical trials and 
commercialized or were unsuccessful. The discovery of the first three 
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antimicrobials i.e., Salvarsan, Prontosil and penicillin was exemplary in the set 
up for drug discovery (Aminov 2010). Between 1950s and 1970s, were the 
golden era of discovery of antibiotics, with no new groups of compounds 
discovered since then (Aminov 2010). These antimicrobials were then 
classified to different groups of antibiotics following their target and 
mechanism of action and its chemical structures.  
 
Currently, antimicrobial classes used for infectious diseases include 
aminoglycosides, carbapenems, cephalosporins, fluoroquinolones, penicillins 
DQG YDQFRP\FLQ 3HWHUVRQ  &RDWHV HW DO  OLVWHG RXW ȕ-lactams, 
cephalosporins, carbapenems, aminoglycosides, tetracyclines, macrolides, 
glycopeptides, sulphonamides and quinolones as main classes of antibiotics, in 
which some are commercialized and some are withdrawn. 
 
2.6.3.1 Treatment for Staphylococcus aureus Infections 
Penicillin still remains the drug of choice for isolates that is sensitive to it. For 
ȕ-lactamase producing strains, a semisynthetic penicillin (oxacillin) is used. 
Vancomycin is preferred for methicillin-resistant strains, though for patients 
that are unable to tolerate vancomycin, they can be treated with 
fluoroquinolones, clindamycin or minocycline (Lowy 1998). Antimicrobial 
combinations have been used to increase bactericidal activity or prevent 
GHYHORSPHQWRIUHVLVWDQFH7KHFRPELQDWLRQRIȕ-lactams and aminoglycosides 
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increases bacterial killing in vitro and in animal models of endocarditis of 
Staphylococcus aureus (Miller et al., 1978). 
 
The use of topical agents to eliminate Staphylococcus aureus colonization in 
high risk groups, such as patients undergoing dialysis or surgery, has been 
shown to reduce the incidence of infections (Yu et al., 1986). Muciprocin 
which is an anti-staphylococcal topical agent that inhibits RNA and protein 
synthesis, eliminates nasal colonization and can reduce the incidence of wound 
infections (Reagen et al., 1991). 
 
2.6.4 Action Mechanism of Antibiotics 
Antibiotics can be categorized by their modes and site of action. There are 
antibiotics which are inhibitors of cell wall synthesis, distruptors of cell 
membranes, inhibitors of protein synthesis and inhibitors of nucleic acid 
synthesis as tabulated in Table 2.2. 
 
  
52 
Table 2.2. Antibiotics categorized by their modes of action. 
Mode and site of action Antibiotic Origin 
Inhibitors of cell wall synthesis Penicillins (Penicillin G, oxacillin, 
ampicillin, amoxicillin) 
Fungi Penicillium notatum or 
Penicillium chrysogenum 
Cephalosporins (Cephalexin, cefradroxil) Fungi Cephalosporium sp. 
Carbapenems (Bacitracin, primaxin, 
vancomycin) 
Bacitracin ± Bacillus lincheniformis 
Vancomycin ± Streptomyces orientalis 
Distrups cell membrane Polymixin (Polymixin B) Bacillus polymyxa 
Inhibitors of protein synthesis Aminoglycosides (Streptomycin, 
gentamicin, kanamycin) 
Streptomyces and micromonospora sp. 
Tetracycline   
Chloramphenicol Streptomyces sp. 
Inhibitors of nucleic acid Rifampin Semi synthetic, originally from 
Streptomyces mediterranei  
Quinolones Synthetic  
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2.6.4.1 Inhibitors of Cell Wall Synthesis 
ȕ-lactam antibiotics are a broad class of antibiotics which consists of all 
antibiotics which contain D ȕ-lactam nucleus in their molecular structure 
(Figure 2.11). These include penicillin derivatives, cephalosporins, and 
carbapenems (Holten & Onusko 2000). All these antibiotics target the cell 
wall. ȕ-lactam antibiotics inhibit the growth of bacteria by inactivating 
enzymes located in the bacterial cell wall. They act by covalently combining 
with penicillin binding proteins (PBPs) and inactivating transpeptidase and 
carboxypeptidase activities that are responsible for catalyzing the final 
transpeptidation step of bacterial cell wall biosynthesis (Waxman & 
Strominger 1983). 
 
The HIIHFWLYHQHVV RI ȕ-lactam antibiotics relies on their ability to reach the 
penicillin binding protein (PBP) intact and ability to bind to PBP. Hence, 
UHVLVWDQFHWRȕ-lactam antibiotics occurs by four primary mechanisms (Drawz 
& Bonomo 2010): 
1) Production of ȕ-ODFWDPDVH HQ]\PHZKLFKZLOO K\GURO\]H WKHȕ-lactam 
ring of the antibiotic, rendering the antibiotic ineffective  
2) /RZDIILQLW\RIWKHDFWLYHVLWHRI3%3VIRUȕ-lactam antibiotics through 
natural transformation and recombination 
3) Decreased expression of outHU PHPEUDQH SURWHLQV DV ȕ-lactams must 
diffuse through or traverse porin channels in the outer membrane of 
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Gram-negative cell walls in order to access the penicillin binding 
protein (PBPs) on the inner plasma membrane. This mechanism of 
resistance has been identified for carbapenem antibiotics. 
4) Upregulation of the efflux pump which are capable of exporting 
subtrates from the periplasm to the surrounding environment can 
contribute to decreased susceptibility to penicillins and cephalosporin. 
 
x Penicillins 
Penicillin is a group of antibiotics derived from Penicillium fungi (Black 
2002). Some commercially used derivatives of penicillin includes penicillin V, 
amoxicillin, ampicillin, oxacillin and carbenicillin. Penicillin G is the most 
used natural penicillin that is used in treating infections caused by streptococci, 
meningcocci, pneumococci and clostridia (Black 2002). Other penicillins such 
as ampicillin, oxacillin and amoxicillin are semi-synthetic. In addition to their 
use as treatments for infections, penicillins are also used to prevent infection. 
For example, patients are given penicillin before dental surgery to prevent 
infections.  
 
x Cephalosporins 
&HSKDORVSRULQDQWLELRWLFVDUHWKHVHFRQGPDMRUJURXSVRIȕ-lactam antibiotics 
after penicillins. Classification of cephalosporins is by generation, as it reflects  
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(c) 
Figure 2.11 ȕ-lactam pharmacophore in the molecular stUXFWXUH RI ȕ-lactam 
antibiotics (a) Penicillin, (b) Cephalosporin and (c) Carbapenem. (R, R1, R2 
and R3: different functional groups)  
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their antibacterial activity. First generation cephalosporins have good activity 
against Gram-positive cocci. Second generation cephalosporins have enhanced 
activity against Gram-negative bacteria. A further increase in potency against 
Gram-negative bacteria, including against Enterobacteriaceae such as 
Pseudomonas sp, Klebsiella sp. and Shigella sp, is a characteristic of the third 
generation cephalosporins, though these compounds are less active against 
Gram-positive cocci compared to the first generation agents. The fourth 
generation cephalosporins are activite against both Gram-positive and Gram-
negative bacteria and are more stable DJDLQVW ȕ-lactamases (Mason & 
Kietzmann 1999). Cephalosporins includes first generation cefadroxil and 
cephradine, second generation cefaclor and cefprozil and third generation 
cefixime and cefdinir (Holten & Onusko 2000). Fourth generation cefepime is 
also reported (Mason & Kietzmann 1999). 
 
Cephalosporins are bactericidal and acts by inhibiting cell wall synthesis. 
Bacterial resistance is known by the production of enzymes which hydrolyze 
WKH ȕ-lactam ring. Currently, cephalosporins are used for urinary and 
respiratory tract infections, otitis media, meningitis and in skin and soft tissue 
infections (Mason & Kietzmann 1999).  
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x Carbapenems 
Carbapenems are a new ȕ-lactam bactericidal antibiotic which is characterized 
ZLWKWKHȕ-lactam ring with a carbon instead of a sulfone in the moiety (Figure 
2.11). The first carbapenem to be used was the antibiotic imipenem, which was 
coadministered with cilastatin, a compound that prevents the degradation of the 
compound in the kidneys (Bonfiglio et al., 2002).  Other carbapenems in use 
are meropenem and doripenem. The mechanism of action of carbapenems are 
VDPHZLWKRWKHUȕ-lactams, by inhibiting the cell wall synthesis via inactivation 
of transpeptidase and inhibition of the formation of peptide cross linking 
bonds, thus breaking the cell wall integrity. 
 
2.6.4.2 Distruption of Bacterial Membrane 
x Polymixin 
Polymixins are polypeptide antibiotics which are effective especially against 
Gram-negative bacteria, as they act upon the cell membrane. Polymixins act as 
detergent and distorts the bacterial cell membrane, by binding to 
phospholipids. Distortion of the cell membrane results in leakage of the cell 
contents and thus cidal to the bacteria (Kioke et al., 1969). Gram-negative 
bacteria membranes are rich in phospholipids.  
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2.6.4.3 Inhibitors of Protein Synthesis 
x Aminoglycosides 
Aminoglycosides refers to a family of molecules containing amino-modified 
sugars linked by glycosidic bonds, and functions as antibiotics (Figure 2.12). 
Currently available aminoglycoside antibiotics are streptomycin, gentamicin, 
kanamycin and neomycin. Aminoglycosides are used in the treatment of severe 
infections of the abdomen and urinary tract, bacteremia, and endocarditis (Jana 
& Deb 2006). It has the advantage to elicit broad antimicrobial spectrum, rapid 
bactericidal action and ability to act synergistically with other drugs (Jana & 
Deb 2006).  Due to their structure, these antibiotics are considered 
polycationic, which enable them to show binding affinity for negatively 
charged residues in the outer membrane and in nucleic acids such as the 16S 
rRNA of the 30S ribosome. 
 
Aminoglycosides are bactericidal by inhibiting protein synthesis as they bind 
to the 16S rRNA, a component of the 30S small subunit of ribosome, and 
disrupts the integrity of bacterial cell membrane. Resistance with this type of 
antibiotics occur with mechanisms including (Shakil et al., 2008): 
1) Deactivation of aminoglycosides by N-acetylation, adenylation or O-
phosphorylation  
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2) Reduction of intracellular concentration of aminoglycosides by changes 
in outer membrane permeability, decreased inner membrane transport, 
active efflux and drug trapping 
3) Alteration of the 30S ribosomal subunit target by mutation 
4) Methylation of the aminoglycosides binding site. 
 
x Tetracyclines 
Tetracyclines are a group of broad-spectrum antibiotics which are named for 
WKHLU IRXU µWHWUD¶ K\GURFDUERQ ULQJV QDSKWDFHQH ULQJ 7HWUDF\FOLQH
derivatives are different with substitution at position 5, 6 and 7 which is the 
conserved region (Figure 2.13). The pharmacophore lays with position 2, 3, 4, 
10, 11, and 1 where modifications are not tolerated without loss of activity. 
Tetracycline penetrates bacterial cells by passive diffusion and inhibits 
bacterial growth by interfering with protein synthesis. This happens as 
tetracycline binds to the 30S subunit of the ribosome during protein synthesis, 
and inhibits binding of the t-RNA to the matching codons. As a result, protein 
synthesis does not occur (Chopra & Roberts 2001).  
 
There are two groups of tetracycline distinguished by its different mechanism 
of action, which are the typical tetracycline (bacteriostatic, Figure 2.14a) and 
tetracycline derivatives which are bactericidal (Schnappinger & Hillen 1996). 
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 (a)                                                           (b) 
 
 
(c) 
 
Figure 2.12. Backbone structures of aminoglycosides (a) 2-deoxystreptamine 
(b) streptidine and (c) streptomycin. 
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The bacteriostatic mechanism of typical tetracyclines such as tetracycline, 
doxycycline and minocycline, are associated with reversible inhibition of 
protein synthesis by reversible binding of the tetracycline to the ribosome, thus 
distorting the alignment of the anticodons of the t-RNA to the codons of the 
mRNA.  
 
Chelocardin, anhydrotetracycline (hydrochloride) and 6-thiatetracycline 
(Figure 2.14b) are tetracycline agents that are bactericidal due to their ability to 
cause morphological alterations of the bacterial cell and cause cell lysis (Oliva 
et al., 1992). This is reflected by the UHOHDVH RI ȕ-galactosidase from the 
cytoplasm. These agents may promote cell lysis and death by interfering with 
electrochemical gradient thus, stimulates autolytic enzyme activity and cellular 
lysis (Oliva et al., 1992). Although the latter group of tetracyclines are 
bactericidal, these derivatives are of no therapeutic value as its application 
leads to severe side effects (Rogalski 1985). 
 
According to Speer et al. (1992), bacteria use three strategies to derive 
resistance to tetracycline: by limiting access of tetracycline to ribosomes, by 
altering the ribosome to prevent effective binding of tetracycline, and by 
producing tetracycline inactivating enzymes. All of these three types of 
resistance have been found in clinical isolates.  
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(a) 
 
 
(b) 
 
Figure 2.13. Conserved region and numbering scheme for tetracyclines 
antibiotics 
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(a) 
 
 
(b) 
 
Figure 2.14a. Typical tetracycline structures which are bacteriostatic. (a) 
Doxycycline, (b) Minocycline 
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(a) 
 
 
(b) 
 
Figure 2.14b. Tetracycline derivatives which are bactericidal. (a) Anhydro-
tetacycline (hydrochloride), (b) Chelocardin. 
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x Chloramphenicol 
Chloramphenicol is an bacteriostatic antibiotic which originally is obtained 
from Streptomyces venezuelae. Currently this antibiotic is fully synthesized in 
laboratories. It has a broad spectrum of activity and is usually prescribed for 
thyphoid fever, meningcocci infections, Haemophilus influenza infections, 
brain abcess and Rickettsiae infections (Black 2002). Although it is an 
effective broad spectrum antibiotic, it is not the first line antibiotics of use as it 
is known to cause serious side effects such as elevated chloramphenicol serum 
concentrations, anemia, thrombocytopenia, reticulocytopenia, and severe 
metabolic acidosis (Wiest et al., 2012). Currently, chloramphenicol is 
prescribed for eye infections.  
 
Chloramphenicol is bacteriostatic by inhibition of protein biosynthesis via 
inhibition of transpeptidation. Chloramphenicol binds to the 50S subunit of the 
ribosome and blocks the binding of aminoacyl moiety of the tRNA to the 
mRNA complex. Peptide at the donor site is thus unable to be transferred to the 
amino acid acceptor and inhibits synthesis (Balbi 2004).  
 
2.6.4.4 Inhibitors of nucleic acid 
x Rifamycin 
Rifampicin is a semi-synthetic antibiotic from the group rifamycin produced 
by Streptomyces mediterranei which blocks RNA transcription (Black 2002). 
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Although it is a broad spectrum bactericidal antibiotic, it is only approved for 
the treatment of tuberculosis and eliminating meningococci from the 
nasopharynx of carriers as resistance towards rifampin develops rapidly (Black 
2002). Treatments of tuberculosis patients with rifampin has to be daily, 
strictly monitored and cannot be stopped due to the rapid development of 
resistance towards the drug.  
 
Rifamycin specifically inhibits bacterial RNA polymerase which is the enzyme 
responsible for DNA transcription, by forming a stable drug-enzyme complex. 
Mammalian enzymes are not affected by rifamycin. Bacterial resistance is 
usually caused by mutation which leads to a change in the structure of the 
RNA polymerase (Wehrli 1983) 
.  
x Quinolones and Fluoroquinolones 
Quinolones are a group of synthetic antibiotic which are effective against 
Gram-positive and Gram-negative bacteria. Floroquinolones are a major subset 
of this antibiotics which have a florine atom attached to the ring at C-6 or 7 
position (Figure 2.15).  The first quinolone was nalidixic acid which was 
LQWURGXFHG LQ WKH ¶V WKHQ VXEVHTXHQWO\ WKH VHFRQG WKLUG DQG IRXUWK
generation of quinolones was introduced. Table 2.3 shows the first, second, 
third and fourth generation quinolone antibiotics. 
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Table 2.3. First, second, third and fourth quinolone antibiotics (Class et al. 2002). 
Generation Antimicrobial activity Improvements 
First 
Nalidixic acid 
Cinoxacin 
Enterobacteriaceae Narrow Gram-negative coverage 
Oral administration 
Second (Class I) 
Lomefloxacin 
Norfloxacin 
Ecoxacin 
Enterobacteriaceae Improved Gram-negative coverage 
Limited Gram-positive coverage 
Oral administration 
Second (Class II) 
Ofloxacin 
Ciprofloxacin 
Enterobacteriaceae 
Pseudomonas aeruginosa 
(Ciprofloxacin) 
Broader spectrum of pathogens 
Oral and intravenous administration 
Higher serum, tissue and intracellular drug concentrations 
Third 
Levofloxacin 
Sparfloxacin 
Enterobacteriaceae, 
Pseudomonas aeruginosa, 
Streptococci 
Broader spectrum including Streptococci 
Oral and intravenous administration 
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Moxifloxacin 
 
Trovafloxacin Enterobacteriaceae, 
Pseudomonas aeruginosa, 
MSSA, Streptococci 
Improved Gram-positive coverage 
Oral and intravenous administration 
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 (a) (b) 
 
 
 
  
 (c) (d) 
 
Figure 2.15. Quinolones and floroquinolones antibiotic. (a) Nalidixic acid, (b) 
Ofloxacin, (c) Ciprofloxacin, (d) Norfloxacin. 
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Quinolones and fluoroquinolones inhibits bacterial replication by inhibiting 
DNA replication. DNA replication is essential as it contains the genetic 
material which enables the bacteria to function. In replication, the double 
stranded DNA is unwind to a single stranded form which allows synthesis of 
mRNA. This unwinding of the double stranded DNA is done by a 
topoisomerase II enzyme which is DNA gyrase. Quinolones and 
fluoroquinolones bind to a subunit of this enzyme and alters the active binding 
site of the enzyme, inhibiting it to continue the replication of the DNA (Hooper 
1999).  
 
2.6.5 Isolated Antibacterial Agents from Flowering Plants 
Approximately 11500 from 30000 antibacterial agents are isolated from 
flowering plants according to Berdy (2005), demonstrating the importance of 
flowering plants as a source of antibiotics. Plants have unlimited ability to 
synthesize metabolites which serve as plant defense against microorganisms 
(Cowan 1999). Reported to be antibacterial metabolites are phenolics, 
terpenoids, alkaloids, polypeptide and polyacetylenes (Cowan 1999).  
 
Among the earliest isolation of antibacterial from plants would be the isolation 
of eugenol from cloves (Syzygium aromaticum (L.) Merr. & L.M. Perry) and 
thymol from thyme (Thymus mongolicus (Ronniger) Ronniger) (Hitokoto et 
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al., 1980). Quinine is another alkaloid that has been identified with 
antibacterial properties isolated from Cinchona calisaya Wedd. (Greenwood 
1992). Cinnamomum osmophloeum  Kaneh. has shown to possess antibacterial 
property against Escherichia coli, Enterococcus faecalis, Staphylococcus 
aureus and Methicillin-resistant Staphylococcus aureus (MRSA) with 
cinnamaldehyde being the main antibacterial component.  
 
Recently, antibacterial compounds are being actively isolated from plants 
using better technologies in elucidation of compounds such as alkaloids, 
phenolics and terpenes. Quidoline and cryptolepine were identified from GC-
MS analysis of an alkaloid extract of Sida acuta Burm f. used traditionally in 
Africa (Karou et al., 2011). A compound oleanolic acid isolated from 
Carpobrotus edulis (L.) N.E. Br. was identified very active against 
Enterococcus faecalis and Staphylococcus aureus. It has also shown inhibition 
of Mycobacterium tuberculosis (Martins et al., 2011).  Eight compounds are 
isolated from Trichodesma indicum (L.) Lehm. root extract and all eight 
compounds are antibacterial with a glucoside of a tetracyclic triterpene lactone 
(lanast-5-en-ȕ-D-glucopyranosyl-21 (24)-olide) being the most active 
compound against Staphylococcus aureus at a minimum inhibition 
concentration value of 2.4 µg/mL (Periyanayagam et al., 2012). 
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 (a) (b) 
 
 (c) (d) 
 
(e) 
Figure 2.16. Antibacterial agents isolated in the earlier years (a) Eugenol, (b) 
Thymol, (c) Cinnamaldehyde, (d) Papaverine, (e) Quinine 
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(a) (b) 
 
 
 
(c) 
 
Figures 2.17 (a). Antibacterial agents isolated from flowering plants (a) 
Quidoline, (b) Cryptolepine, (c) Oleanol acid. 
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Figures 2.17 (b). Antibacterial agents isolated from flowering plants - Lanast-
5-en-ȕ-D-glucopyranosyl-21 (24)-olide. 
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2.6.6Tests to Assess Antibacterial Properties 
Methods to assess antibacterial properties of compounds and medicinal plants 
are classed into three groups which are diffusion method, dilution method and 
bioautographic method (Rios et al., 1988).  
 
2.6.6.1 Diffusion Method 
In a diffusion method, the sample is brought into contact with the bacteria via a 
reservoir containing the sample. The reservoirs commonly used are cups, holes 
in agar or discs. Upon incubation, the diameter of a clear zone around the 
reservoir indicates inhibition of the bacterium. This method was originally 
applied to assess effectiveness and selectivity of antibiotics (Rios et al., 1988). 
 
Diffusion methods are the most employed method in antibacterial research due 
to its advantages. The advantages of diffusion methods are the small size of the 
sample used in screening and the possibility of testing five or more compounds 
against a single microorganism. Diffusion methods are well suited for 
preliminary screening of pure substances and crude extracts. Although it is 
widely used by many researchers, the disadvantage to these methods is that it 
is not appropriate to be used with samples that are not soluble in water such as 
essential oils and non polar extracts. Diffusion methods can be used as a 
screening tool, but results from it alone can never be used for definitive 
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activity, thus, it is a common practice to test with more than one method for 
definite assessment. 
 
2.6.6.2 Dilution Method 
Dilution techniques are methods which require a homogenous dispersion of the 
sample in broth or water. Dilution methods are commonly used to determine 
the minimum inhibition concentration (MIC) and the minimum bactericidal 
concentration (MBC) of compounds or extracts. In the dilution method, 
turbidity is an indication of bacterial density and growth. Thus, clear medium 
indicates no growth. Inhibitions are indicated to the turbidity of the medium 
and are measured either visually or by a spectrophotometer (Rios et al., 1988). 
Dilution method can be done in either liquid or agar form. Dilution in liquid 
medium is more laborious but is the most precise technique (Rios et al., 1988). 
Currently, the microbroth dilution method is sought for high throughput 
screening of extracts and compounds as it only requires a small amount of 
sample and accommodates more samples to be assessed. 
 
2.6.6.3 Bioautographic Methods 
Bioautographic methods are in situ method applying the biological effect that 
is assessed, in this case antibacterial. Bioautographic methods are commonly 
using paper chromatography or thin layer chromatography, whereby the 
antibacterial compound is transferred from the chromatographic layer to an 
 77 
inoculated agar plate. Inhibition zones are visualized by dehydrogenase 
activity detecting reagents. Rapid and efficient detection of active compounds 
can be achieved through bioautographic method. With this method, it is 
possible to localize antimicrobial activity on a chromatogram. Inhibition zones 
are observed directly on the TLC plate. The disadvantage of the method is that 
it requires more complex microbiological equipment.  
 
2.7 Antioxidant and Cytoprotective Agents from Flowering Plants 
 
2.7.1 Diseases Resulting from Oxidative Stress 
Normal metabolism produces reactive oxygen species (ROS) which cause 
damage to DNA, proteins, and lipids hence ageing and neurodegenerative 
diseases (Ames et al., 1993). Reactive oxygen species (ROS) are generated by 
perixosomes, mitochondria, and cell activation and are quickly neutralize by 
Glutathione (GSH) (Jatawa et al., 2012). However, exogenous sources like 
oxides of nitrogen in smoke, ultraviolet light, ionization radiation, 
environmental toxins and from metals and ions overcome glutathione (GSH) 
capacities in cells and oxidants are able to insult the cells which often undergo 
apoptosis (Noh & Ha 2011). 
 
In fact, oxidative stress has been recognized to be involved in the diagnosis of 
several chronic conditions including cardiovascular diseases, cancer, diabetes, 
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arthritis, nephrophathy and skin ageing (Ames et al., 1993; Jatawa et al., 2012). 
It is also the major cause for minor illness, fatigue, infertility and aging. 
Studies have recognized the involvement of ROS in the etiology of liver 
diseases such as hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma 
(Vitaglione et al., 2005). Liver is a vital organ which plays a major role in 
metabolism including glycogen storage, plasma protein synthesis, hormone 
production and detoxification of the body.  
 
Antioxidants refer to any substance that delays, prevents or removes oxidative 
damage to a target molecule (Gutteridge & Halliwell 2010). Antioxidants 
comprise a broad and heterogeneous family of compounds that interfere with 
the oxidation of any oxidizable substrate (Halliwell & Gutteridge 2007). 
Antioxidants scavenge free radicals such as superoxides which accumulate in 
the body at a rate of 1 % per day at rest and increases 10-fold during exertion 
(Halliwell 1994). Consequently, mechanisms of protection of liver are 
compelling, and natural antioxidants are soughed to counteract oxidative stress 
especially from flowering plants (Wiart 2006). 
 
2.7.1.1Cancer 
It is estimated that as much as 7.6 million deaths are caused by cancer 
worldwide in 2008. Cancer incidences in less developed countries are expected 
to increase 56 % in 2008 to more than 60 % in 2030 (Jemal et al., 2010). The 
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most common diagnosed cancer among men in Asia is lung cancer and breast 
cancer in women in most of the region worldwide (Jemal et al., 2010). Cancer 
is fundamentally a disease of regulation of cell and tissue growth and its 
development is a multi stage process which is termed carcinogenesis (Valko 
2007).  
 
Carcinogenesis can be described in three stages which are the initiation stage, 
promotion stage and the progression stage. ROS are claimed to act in all the 
three stages of carcinogenesis (Klaunig & Kamendulis 2004). A non-lethal 
mutation in DNA which produces altered cell is the initiation step of 
carcinogenesis. The mutation is then followed by one round of DNA synthesis 
to repair the damaged DNA produced. The promotion stage is where the clonal 
expansion of the initiated cells by the induction of cell proliferation or 
inhibition of apoptosis, thus results in the formation of identifiable focal lesion.  
 
Progression is the final stage of carcinogenesis which involves cellular and 
molecular changes that occur from the preneoplastic to the neoplastic stage. 
ROS-induced DNA damage involves single or double stranded DNA breaks, 
purine, pyrimidine, or deoxyribose modifications, and DNA cross-links. DNA 
damage can result in either arrest or induction of transcription, induction of 
signal transduction pathways, replication errors, and genomic instability, all of 
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which is related to either one of the stages in carcinogenesis (Valko et al., 
2006; Valko et al., 2007). 
 
2.7.1.2 Neurodegenerative Diseases 
An increasing number of proofs indicate a role of oxidative stress in several 
steps of the pathogenesis of many neurodegenerative diseases as changes 
related to oxidative stress have been observed in brain tissues and peripheral 
WLVVXHVIURPSDWLHQWVRI$O]KHLPHU¶VGLVHDVH+XQWLQJWRQ¶VGLVHDVH3DUNLQVRQ¶V
disease and Amyotrophic Lateral Sclerosis (Migliore & Coppede 2009). 
Various neurodegenerative diseases have different symptoms, effect different 
part of the brains and have different causes. In fact, many of them are being 
studied on extensively and are being reviewed by excellent researchers. 
Halliwell (2006), have summarized the common affects and symptoms in the 
diseases which are impaired mitochondrial function, increased oxidative 
damage, defects in the ubiquitin-proteasome system, presence of abnormal and 
aggregated proteins, changes in iron metabolism and involvement of 
inflammation. 
 
2.7.1.3 Ageing 
The ageing process is a normal feature in the life cycle of all organisms, in 
which the functionality capacity of a variety of physiological systems 
deteriorates, attenuating the ability to maintain normal homestasis (Sohal et al., 
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2002). A popular hypothesis of the cause of aging is accumulation of 
molecular oxidative damage induced by reactive oxygen species, which leads 
to senescence associated loss in physiological functions (Sohal 2002). Normal 
mitochondria metabolism produces ROS, as between 0.4 and 4 % of the 
oxygen consumed by the mitochondria is converted to ROS and will readily 
cause damage to biomolecules including DNA, protein and membrane lipids, 
thus define aging symptoms (Golden et al., 2002). The concept of ageing is 
supported by studies in many animals showing that ageing is associated with 
accumulation of oxidized forms of proteins, and it was proposed that ROS 
mediated protein damage is involved in the process (Valko et al., 2007). 
 
The goal of ageing research is not to extend the lifespan of humans, but to 
improve and extend the functional lifespan of ageing individuals (Golden et al., 
2002). As it is accepted as a normal cycle, therapeutic compounds are sought 
to maintain normal homeostasis of the body until the end of lifespan. Indeed, 
antioxidants are used either as functional food or incorporated to anti-aging 
formulations. Many natural product antioxidants are being sought and used as 
its safety and effectiveness is more trusted (Masaki 2010). 
 
2.7.1.4 Inflammation 
Inflammation is a spontaneous response of a normal body to any cellular or 
tissue injury to destroy and remove the cause of the injury, the injured tissues 
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and promote tissue repair. An uncontrolled response leads to excessive cellular 
and tissue damage that result in chronic inflammation and destruction of 
normal tissue. ROS are released by phagocytes to the sites of inflammation, 
thus causing the cell and tissue damage which includes apoptosis, and other 
chronic inflammatory diseases (Morcillo et al., 1999; Rahman & MacNee 
2000). 
 
2.7.2 Action Mechanism of Antioxidants 
Gutteridge (1993) explained the different mechanisms of action of antioxidants 
which: 
1. Removing oxygen or decreasing local oxygen concentrations 
2. Removing catalytic metal ions 
3. Removing key reactive oxygen species (ROS) such as O2- and H2O2 
4. Scavenging initiating radicals such as OHƔ, ROƔ, RO2Ɣ 
5. Breaking the chain of an initiated sequence 
6. Quenching or scavenging singlet oxygen. 
 
 Many antioxidants have more than one mechanisms of action. Aruoma (1994) 
classify antioxidants based on their mechanism of action, either as scavengers 
of free radicals, preventers of the formation of a radical or by repairing the 
damage caused. Relative importance of antioxidants in vivo relies on types of 
ROS that are generated, the source of generation and the type of environment it 
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is generated in. Hence, it is possible that an antioxidant may protect in one 
system but fail to protect, or may cause damage in another system (Halliwell et 
al., 1995).  
 
2.7.2.1 Flavonoids  
Flavonoids are known to display a wide range of pharmacological and 
biochemical properties and have long been recognized to possess anti-
inflammatory, antimicrobial, anticarcinogenic, hepatoprotective and 
antioxidant activities (Kandaswami & Middleton 1997). Flavonoids are classed 
upon its structural differences to few classes which are flavones, isoflavonoids, 
chalcones, flavanones, flavanols and anthocyanins. Isoflavones were by far the 
most potent inhibitors of lipid peroxidation with the position of the singlet 
phenolic group (OH) in the chromane ring of alpha tocophenol corresponds to 
the 6-OH group of the isoflavonoids. A common feature of the active 
isoflavonoids is an ortho-dihydroxy benzene or cathechol structure, which is 
considered to be important for antioxidative effectiveness of flavonoids.  
 
Flavonoids can function as metal ion chelators and reducing agents, scavengers 
of ROS, chain-breaking antioxidants and quenchers of the formation of singlet 
oxygen. Protection of ascorbic acid appears to be one of their primary 
functions (Kandaswami & Middleton 1997). Flavonoids are antioxidant owing 
WR WKHLU FRQMXJDWHG ʌ-electron system which makes donation of electron or 
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hydrogen atoms possible from the hydroxyl moieties to free radicals (Gupta & 
Verma 2010). The antioxidant efficacy depends on their structural features 
such as the number and position of the hydroxyl moieties on the ring system 
and the unpaired electron in the oxidized phenolic intermediate (Gupta & 
Verma 2010).  
 
Bors et al. (1990) suggested that there are three structural groups that are 
important determinants for radical scavenging and antioxidant potential which 
are:  
1) The O-dihyroxy catechol structure in the B ring, which is the obvious target 
site for all flavonoids with a saturated 2, 3 bond 
2) The 2,3 double bond in conjugatLRQ ZLWK D Į-4-oxo function, which is 
responsible for electron delocalization from the B ring 
3) The additional presence of both 3- and 5-hyroxyl groups for maximum 
radical scavenging potential and strongest radical absorption. 
 
Flavonoids scavenge radicals effectively forming semiquinone free radical in 
alkaline solution. The semiquinone free radical or aroxyl radical may react 
with a second radical, acquiring a stable quinine structure (Figure 2.18). It is 
proposed that O-dihydroxyl structure in ring A makes better antioxidant than 
others (Tiwari 2001). 
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Figure 2.18. Scavenging of ROS (RƔ) by flavonoids and formation of a stable 
structure. 
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2.7.2.2 Alkaloids 
Alkaloids contain one or more nitrogen atoms usually in combination as part of 
a cyclic system (Harborne 1984). A considerable number of alkaloids are 
specific to one family or few related plants. For instance, atropine from Atropa 
belladonna L. and colchicine from Colchicum autumnale L. (Harborne 1984). 
The presence of aromatic ±OH group are partially responsible for their 
antioxidant efficiency, similar to phenolic antioxidants (Rackova et al., 2004).  
 
A study on the structural aspects of alkaloids as antiradicals and antioxidants, 
which involves three alkaloids, berberine, jatrorrhizine and magnoflorine. 
(Figure 2.19) from Mahonia aquifolium (Pursh) Nutt. shows that alkaloids 
bearing unsubstituted ±OH groups in jatrorrhizine and magnoflorine, proved to 
be able to scavenge free stable radical with the dihydroxylated alkaloid. 
Magnoflorine gives similar result to the standard used. Berberine, with absence 
of ±OH groups showed only negligible activity which is in accord to the lack 
of any abstractable hydrogen (Rackova et al., 2004). 
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 (a) (b) 
 
 
(c) 
 
Figure 2.19. Alkaloids from Mahonia aquifolium (Pursh) Nutt. (a) Berberine, 
(b) Magnoflorine and (c) Jatrorrhizine. 
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2.7.2.3 Carotenoids 
Carotenoids are C40 tetraterpenoids which are widely distributed group of lipid 
soluble compounds. In plants, carotenoids have two essential functions which 
are as pigments in photosynthesis and as coloring matters in flowers and fruits 
(Harborne 1984). Although there are many identified carotenoids, but only a 
few are common in higher plants. Well known carotenoids are either simple 
unsaturated hydrocarbons lycopenes or their oxygenated derivatives 
xanthophylls. The chemical structure of lycopene (Figure 2.20a), comprise of 
eight long chain of isoprene units joined head to tail, which gives it a 
conjugated system of alternate double bonds, which is the chromophore. 
Common xanthophylls are either monohydroxycarotenes (lutein), 
dihydroxycarotenes (zeaxanthin) or dihydroxyepoxycarotenes (violaxanthin) 
(Figure 2.20b -c). 
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(a) 
 
(b) 
 
Figure 2.20 (a). Antioxidant carotenoids (a) Lycopene, (b) Lutein 
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(c) 
 
 
(d) 
 
Figure 2.20 (b). Antioxidant carotenoids (c) Zeanthin and (d) Violaxanthin. 
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Carotenoids are photoprotectants in both human and plant tissues, as they 
quench and inactivate ROS and become a radical themselves. Carotenoid 
radicals are stable owing to delocalization of unpaired electrons over the 
conjugated polyene chain of the molecules. This delocalization allows addition 
reaction to occur at many sites of the radical (Gupta & Verma 2010). 
 
2.7.2.4 Phenolic acids and Tannins 
Phenolic acids are antioxidant and studies showed that high antioxidant 
activity are present in molecules containing at least two neighboring phenolic 
hydroxyl groups (Cuppett et al., 1997). According to Dziedzic and Hudson 
(1984), a carbonyl group, such as an aromatic acid, an ester or a lactone, 
enhances the antioxidant activity of the phenolic acids. Besides that, stearic 
hindrance of the phenolic hydroxyls by a neighboring methoxyl group also 
enhances antioxidant activity. 
 
Phenolic acids inhibit lipid peroxidation by trapping the peroxy radical in one 
of the two mechanism. In the first mechanism, the peroxy radical (LOOƔ) 
abstracts a hydrogen proton from the antioxidant (ArOH) to yield an aroxyl 
radical (ArOƔ) and the hydroperoxide (LOOH). In the second mechanism, a 
peroxy and an aroxyl radical react by radical-radical coupling to from a non 
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radical product (Cuppett et al., 1997). Both of the mechanisms can be pictured 
as below 
Mechanism 1: 
LOOƔ + ArOH Æ LOOH + ArOƔ 
Mechanism 2 : 
LOƔ + ArOƔ Æ LOOAr (non radical product) 
 
2.7.3 Tests to Assess Antioxidant Activity 
As there are different mechanisms underlying each assays used and different 
applications for each, thus combination of different approaches and assays are 
needed to assess a potential antioxidant (Moon & Shibamoto 2009). Generally 
there are 2 general types of assays used; where one is an assay associated with 
OLSLG SHUR[LGDWLRQ LH ȕ-carotene bleaching assay and another is associated 
with electron or radical scavenging property of the antioxidant i.e., ferric 
reducing antioxidant power (FRAP) assay and the diphenyl-picrylhydrazyl 
(DPPH) radical scavenging assay (Moon & Shibamoto 2009). According to 
Huang et al. (2005), to accurately estimate antioxidant potential of a sample, 
one or more method should be used covering the mechanism of different 
antioxidant reactions i.e., hydrogen atom transfer (ORAC) and electron 
transfer (FRAP and DPPH).  
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Free radical oxidation of lipid components in food is due to a chain of lipid 
peroxidations in fatty acids and their esters, which is responsible for the off-
flavour in foods (Aruoma 1994). Lipid peroxidation is initiated by ROS as it 
subtracts a hydrogen atom from a methylene group of an unsaturated fatty acid 
and subsequently form free radicals such as peroxyl radical. Once the radicals 
are formed, lipid peroxidations progresses and produce various secondary 
oxidation products. Most antioxidant tests associated with lipid peroxidation 
involves monitoring of hydroperoxides or a specific oxidative secondary 
product (Moon & Shibamoto 2009).  
 
2.7.3.1 ȕ-carotene Bleaching Assay  
,QWKHȕ-carotene bleaching assay used in this study, WKHUHGXFLQJDPRXQWRIȕ-
carotene (radical scavenger) is measured spectrophotometrically at 470 nm as 
it scavenges peroxyl radical (LOOƔ) formed by linoleic acid (lipid) in presence 
of ROS and O2 to form a stabOH ȕ-carotene radical (Figure 2.21). If an 
antioxidant is present in a testing solution, it reacts competitively with the 
peroxyl radical. Therefore, antioxidant effects are monitored with the 
bleaching of the test solution which is the reducing amount of ȕ-carotene. 
 
2.7.3.2 2,2-diphenyl-1-picrylhydrazyl (DPPH) Radical Scavenging Assay  
The DPPH radical scavenging assay implies the theory that an antioxidant is a 
hydrogen donor, by which DPPHƔ accepts hydrogen from an antioxidant. The 
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antioxidant effects are proportional to the reducing amount of DPPHƔ in test 
samples. An easy monitoring of the DPPHƔ is able to be performed as it gives 
strong absorption maximum at 517 nm. The color turns from purple to yellow 
following the formation of a stable DPPH upon absorption of hydrogen from 
an antioxidant (Figure 2.23). This assay is quite popular in natural products 
studies as it is simple and highly sensitive.  
 
2.7.3.3 Ferric Reducing Antioxidant Potential (FRAP) Assay 
The FRAP assay is associated with electron transfer. When a Fe3+-TPTZ 
complex is reduced to Fe2+ form by an antioxidant under acidic conditions, an 
intense blue color is observed which is monitored at 593 nm (Figure 2.22). 
Therefore the antioxidant effect is measured by the reducing capability of an 
antioxidant. The FRAP assay gives fast reproducible results but has to be used 
in an aqueous system and the antioxidants must be water-soluble. 
 
2.7.4 Cytoprotection and Cytotoxicity 
Cytotoxic agents are agents which damages cell at a certain concentration. 
Cytoprotective agents are natural or artificial substances which promote 
defense mechanism and do not have curative effects. They can stimulate 
production of natural cell defenses against cell insults (Meerof 1985). 
Cytoprotection are important to protect cells from ROS and oxidative damages 
that will damage DNA, lipids and proteins intracellular, thus will lead to illness 
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and conditions as mentioned above. Cytoprotection mechanism of antioxidants 
includes (Gutteridge 1993): 
1. Preventing radical formation 
2. Intercepting formed radicals 
3. Repairing oxidative damage 
4. Increasing elimination of damaged molecules 
5. Non repair recognition of excessively damaged molecules in order to 
prevent mutations occurring. 
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Figure 2.21. 0HFKDQLVPRIȕ-carotene bleaching antioxidant assay. 
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Figure 2.22. Mechanism of Ferric Reducing Antioxidant Power (FRAP) assay. Change from Ferric tripyridyltriazine (Fe3+-
TPTZ) complex (Left) to Ferrous tripyridyltriazine (Fe2+-TPTZ) complex (Right) which gives an intense blue colour. 
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Figure 2.23. Mechanism of the DPPH radical scavenging assay. Change from 2,2 Diphenyl-1-picrylhydrazyl free radical 
(DPPHƔ) to 2,2-Diphenyl-1-picrylhydrazyl (DPPH) 
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2.7.5 Tests to Assess Cytoprotection and Cytotoxicity 
 
Cytotoxicity is assessed by methods that observe cell viability and proliferation 
in cell culture. There are a number of methods that are developed in which 
most have been optimized using the 96 well plates and are colorimetric and 
luminescence based (Wayermann et al., 2004). Different parameters associated 
with cell death and proliferation are the basis of the methods developed which 
includes measurement of the cytoplasmic enzyme released i.e., lactate 
dehydrogenase (LDH) (Korzeniewski & Callewaert 1983), metabolic activity 
of viable cell i.e, reducing of tetrazolium salts in MTT (Smith 1951) and 
neutral red assay (DeRenzis & Schechtman 1973), and presence of adenosine 
triphosphate (ATP) (Crouch et al., 1993).  
 
In this study, the neutral red uptake assay was used to analyze cytotoxicity and 
cytoprotective properties of the samples. The neutral red uptake assay is one of 
the most commonly applied cytotoxicity tests with many applications. The 
uptake of QHXWUDOUHGGHSHQGVRQWKHFHOO¶VFDSDFLty to maintain pH gradients, 
through the production of ATP. At physiological pH, the dye is present at a net 
charge close to zero which enables it to penetrate through the membranes of 
the cell. When the cell dies, or the pH gradient is reduced, the dye cannot be 
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retained. Consequently, the amount of retained dye is proportional to the 
number of viable cells (Repetto et al., 2008).  
 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) is a 
water soluble tetrazolium salt. The MTT assay is based on the reduction of the 
soluble yellow MTT tetrazolium salt to a blue insoluble MTT formazan 
product by mithachondrial succinic dehydrogenase (Mosmann 1983). MTT 
assay is used with tumor cells and fibroblast cell lines to evaluate cytotoxicity 
of chemotherapeutic agents (Borenfreund et al., 1988). In a study comparing 3 
cytotoxicity assays (Fotakis & Timbrell 2006), the MTT assay and the neutral 
red uptake assay being the most sensitive assay, showing statistically 
difference between treated cells and the controls. Both assays appear to be 
more sensitive in detecting early toxicity compared to LDH leakage assay.  
 
2.7.6 Current Antioxidant and Cytoprotective Agents from Flowering Plants 
As the demand for antioxidant and cytoprotective agents rises for the treatment 
or preventive measures from oxidative stress conditions, natural sources are 
soughed as an alternative as the natural and herbal sources are non-toxic with 
proven therapeutic benefits and has been used since ancient times (Paul et al., 
2011). Today, more than 70 % of the world population still depends on plant 
sources to meet their health care needs. One of the most important plant 
sources 
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Figure 2.24. (a) Neutral red dye, (b) MTT salt (Left) changes to MTT 
formazan product (Right). 
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with active properties are flowering plants (Wiart 2006).  Flowering plants are 
rich sources of polyphenols which includes anthocyanins, stilbenes, flavonoids, 
tannins and lignins, which are a known for its antioxidant and cytoprotective 
properties (Wiart 2012).  
 
Among known antioxidant and cytoprotective agents from flowering plants are 
quercetin, thymol and carvacrol from Origanum onites L. (Ozkan & Erdogan 
2010). Resveratrol is present in seeds of grapes, in peanuts and berries and has 
profound antioxidant, anti-inflammatory and antiproliferative property. It is 
used in topical applications for protection from Ultraviolet B (UVB) induced 
lipid peroxidations (Svobodova et al., 2003) (Figure 2.25). Epigallocatechin 
gallate (Figure 2.26) from green tea (Camellia sinensis L.) is responsible for its 
antioxidant and anticancer effects (Chen et al., 1998). Curcumin and bis-
demethoxycurcumin from Curcuma longa L. are examples of antioxidant and 
cytoprotective compounds which has been observed to exhibit in vitro and in 
vivo effects (Figure 2.27). Lately, the pharmacokinetics and pharmacology 
aspect of the compounds has been studied and are going through clinical 
human trials (Hatcher et al., 2008). 
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Figure 2.25. Antioxidant and cytoprotective agents from flowering plants (a) 
Quercetin, (b)Thymol, (c) Carvacrol, (d) Resvaratrol, 
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Figure 2.26. Epigallocatechin gallate. 
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(b) 
 
Figure 2.27. Bioactive compounds from Curcuma longa L. (a) Curcumin, (b) 
Bis-demetoxycurcumin. 
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2.8  Approaches in Natural Product Research 
  
Indeed, the demand for antibacterial and antioxidant agents are high as cure for 
these illness and diseases that are caused by bacterial infections and oxidative 
stress are still in need, and the most potential source would still remain to be 
sought from plants. This leads to extensive development in the natural product 
research field. Different approaches are being implemented by different 
research groups in aiming to identify cures from the nature and preparing it to 
EHILQDOO\XVHGDWWKHSDWLHQWV¶EHGVLGH  
 
One of the approaches that are being implemented is random selection of 
plants followed by classical chemical screening. Applying this method, the 
plants are randomly selected and screened for their biological activities with 
simple bioassays. The active plant extract will then be screened for the absence 
and presence of a certain group of compounds with classic phytochemical 
methods. Although the tests are simple to perform, it is usually difficult to 
relate the presence of the compounds with the biological activity that it illicit. 
 
One other common approach that is becoming more popular is the bioassay 
guided fractionation. Scientist applying this approach would choose the plants 
with ethnotraditional applications. The extract would then be screened for its 
activity with a certain bioassay. The active extract would then be fractionated 
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with any means of chromatography and the resulting fractions would then be 
screened again using the same bioassay. The cycle of method will be continued 
until the active constituents are located. Although this approach is more 
directed and focused, it consumes a lot more time and more laborious. Indeed, 
this approach has resulted in isolation of many compounds to date. 
 
In this study, we have opted to use the bioassay guided fractionation approach. 
The plant has been chosen from literature review of its traditional uses and 
previous studies done either in our own lab or other labs. We fractionated the 
active extract and assessed the activity of the fractions with bioassays. The 
active fraction is then further assessed with more specific bioassays and its 
major constituent isolated and elucidated. Other constituents within the 
fraction were identified by comparing the fragments generated by LC-MS with 
the literature present.  
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CHAPTER 3 
MATERIALS AND METHODS 
_______________________________________________________________ 
 
3.1 Instruments 
 
x Grinder 
The dried plant materials were grounded with a heavy duty grinder (Waring, 
USA) into powder form. 
 
x Rotary evaporator 
Extracts and other forms of liquid samples were concentrated using rotary 
evaporator (Buchi, USA) at the range of room temperature to not more than 40 
϶C. 
 
x Freeze drier 
Water extracts and fractions isolated with a high water content was dried using 
a freeze drier (Christ Alpha, Germany). 
 
x Spectrophotometer UV-Vis 
Total phenolic contents were conducted using a UV-Vis spectrophotometer 
from Biochrom Libra S12 (USA). 
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x Microplate reader 
All absorbance based antioxidant, antibacterial and cytoprotective assays using 
96 well plates were measured using Varioskan Flash microplate reader from 
Thermo Fisher (USA) and result were tabulated with ScanIt Software. 
 
x High-performance liquid chromatography (HPLC) 
HPLC analysis of the samples were done with Varian 940-LC (USA) equipped 
with a binary pump, a photodiode array (PDA) detector and fraction collector. 
This HPLC set-up was also used to scale-up separations from analytical scale 
to semi-preparative level in order to perform collections of the samples 
separated. Column used for analytical separations was Zorbax SB-C18 from 
Agilent Technologies (USA) with internal diameter of 4.6 mm, length 150 mm 
and particle size of 5 micron. For semi-preparative scale up, the same column 
was used with internal diameter of 9.4 mm.   
 
x Mass spectrophotometry (MS) 
MS analysis was performed on a LC-MS system (Bruker MicroTOF Q, 
Germany). Analysis was performed in Universiti Kebangsaaan Malaysia 
(UKM). All scan analyses were performed from m/z 150 ± 1500. Column used 
was the same column as analytical separations with HPLC. Conditions were 
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ESI negative mode, capillary 3000v, collision cell RF 250.0 Vpp, nebulizer 0.5 
bar, dry heater 180 °C, dry gas 5.0 L/min.   
 
x Field Emission Scanning Electron Microscopy (FESEM) 
Surface morphology of the bacterial cells were observed and imaged with FEI 
Quanta 400 FESEM. All images are captured with ESEM vacuum wet mode at 
20 000 kV of voltage. Magnification used was 30 000x unless stated otherwise 
in result.   
 
x Nuclear Magnetic Resonance (NMR) 
NMR analyses of the compound(s) were using 600 Ultrashield from Bruker 
(USA) at University of Nottingham UK Campus. 
 
3.2 Materials 
 
Solvents: Hexane, chloroform, ethyl acetate, ethanol, methanol and 
dimethylsulfoxide (DMSO) are all of analytical grade unless specified. 
Acetonitrile for HPLC is of HPLC grade. Water used is of distilled water and 
Ultrapure water (PURELAB Flex, Elga, UK) for HPLC. 
 
Chemicals: DPPH, TPTZ, Trolox, Quercetin. Ascorbic acid, linoleic acid, 
Tween 80, FeCl3, FeSO4, Folin-&LRFDOWHDXUHDJHQWȕ-carotene, Sephadex LH-
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20, propidium iodide, Nisin, ATP, Nigericin, glucose, valinomycin, DiSC3(5), 
MTT and t-BHP were purchased from Sigma, Germany. Gallic acid was 
purchased from TCI, Japan. CellTiter Glo kit was purchased from Promega, 
USA.  
 
Antibiotics: Streptomycin, tetracycline and amphotericin B were from Sigma, 
Germany. Ampicillin was purchased from Amresco, USA. 
 
Media: Mueller-hinton broth (MHB), Mueller-hinton agar (MHA) and potato 
dextrose agar (PDA) were purchased from Hi-Media Labs, India. Minimum 
Essential Eagle Media (MEEM), Fetal bovine serum and phosphate buffer 
saline were purchased from GIBCO, USA. 
 
Bacteria, fungal and cell strains: Bacillus cereus (ATCC 11778), Bacillus 
subtilis (ATCC6633), Staphylococcus aureus (ATCC 11632), Escherichia coli 
(ATCC 8739), Pseudomonas aeruginosa (ATCC 10145), Citrobacter freundii 
(ATCC 809) were all purchased from American Type Culture Collection, 
USA. Methicillin-resistant Staphylococcus aureus (MRSA) were obtained 
from the Department of Medical Microbiology, UKMMC. 
 
Formulation excipients: Emulsifying wax, liquid paraffin, white soft paraffin, 
arachis oil, oleic acid, wool fat, glycerol, cetostearyl alcohol and sodium 
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stearate were all purchased from R&M Chemicals, India. Calcium hydroxide 
was purchased from Sigma, Germany. 
 
3.3 Plant Collection and Extraction 
 
3.3.1 Extraction 
Acalypha wilkesiana var. macafeana hort. was collected at Jalan Broga, 
Semenyih (2϶¶´1RUWK϶¶´(DVWDQGDXWKHQWLFDWHGE\WKH)RUHVW
Research Institute Malaysia (FRIM). The plant was collected in March 2009. 
Aerial part of A. wilkesiana i.e., leaves, stems and flowers, without roots, were 
dried at room temperature (27 ϶C). After it was dried, the plant was grinded 
into powder. The secondary metabolites from the plant were then extracted 
with successive sequential maceration in solvent starting from a non-polar 
solvent to a polar solvent which was hexane, ethyl acetate, ethanol and water in 
sequence. Extraction was done with each solvent for 3 subsequent days with 
1:8 ratio of sample to solvent. All the plant extracts were then concentrated 
using the rotary evaporator at 40 ϶C, and kept in the dessicator until dried. The 
water extract was further dried using a freeze drier to remove all water 
molecules that might be present in the extract. Once dried, all the extracts were 
kept at -80 ϶C prior to use. 
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3.3.2 Fractionation and isolation 
The ethanol extract of A. wilkesiana var. macafeana hort. was then further 
fractionated by column chromatography. Fractionation was done according to 
Adesina (2000) with slight modification. The column (2.5 cm i.d and 40 cm 
length) was prepared using Sephadex LH-20 (25 g) preswollen in 25 % 
aqueous ethanol overnight. The ethanol extract was weighed and dissolved in 
25 % aqueous ethanol. The dissolved extract was filtered (0.45 µm, nylon) 
before loaded into the packed column. Elutions were done with gradient 
increase of ethanol in water starting from 25 % aqueous ethanol, 50 % aqueous 
ethanol, 75 % aqueous ethanol, 95 % ethanol, and finally with 70 % aqueous 
acetone. The elution afforded a total of 5 fractions i.e., F1-F5. Fractions were 
dried with the rotary evaporator with temperature of the water bath not 
exceeding 40 ϶C. The fractions were then used for further assays and analysis 
throughout the research. 
 
3.4 Chemical and Biological Assay on Fractions  
 
3.4.1 Antioxidant screening 
3.4.1.1 TLC Screening with DPPH Spray 
The fractions were qualitatively assessed for their antioxidant properties by 
spraying with DPPH spray prepared with methanol (0.2 % DPPH in methanol). 
This method is a preliminary screening for metabolites with antioxidant 
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property, and can be done very fast. The TLC plate that has been developed 
were left to dry, then sprayed with the DPPH spray and left for thirty minutes. 
Active antioxidant compounds appeared as yellow spots against a purple 
background (Braca et al., 2002). 
 
3.4.1.2  Ferric reducing antioxidant power (FRAP) assay 
The antioxidant capacity was determined following the procedure described by 
Benzie and Strain (1996) with several modifications. FRAP reagent were 
prepared fresh by adding 10 mM TPTZ (dissolved with 40 mM HCl), 20 mM 
FeCl3 in water and 300 mM of acetate buffer in ratio of 1:1:10. Samples and 
standards were prepared at a concentration of 1 mg/mL. Briefly, 20 µL of 
sample were transferred into wells and subsequent dilutions were done on each 
sample until five different concentrations were obtained. 180 µL of FRAP 
reagent were added in each well making the final volume to 200 µL. Sample 
colour corrections were done to subtract off absorbance from the sample due to 
its colour by making a blank devoid of sample and solvents. The microtiter 
plates were then incubated at 37 ϶C for 90 minutes before absorbance were 
recorded at 600 nm. Trolox and quercetin were used as positive control. The 
absorbance was compared to a FeSO4 standard curve and results were 
expressed as mole Fe (II)/g sample.  
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3.4.1.3  DPPH radical scavenging assay 
The antioxidant activity was also studied through the free radical scavenging 
activity of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. The assay was 
conducted on the fractions with reference to Alothman (2009) with slight 
modifications. Samples and ascorbic acid were prepared in the concentration of 
1 mg/mL. 10 µL of samples and ascorbic acid were transferred from stock 
solution of 1 mg/mL into micro wells. Ten fold dilutions of each sample and 
ascorbic acid were done to attain 5 different concentrations. 200 µL of 
methanolic DPPH (50 µM) was added into the tubes, and then thoroughly 
mixed before incubated in the dark at room temperature for 30 minutes. The 
absorbance was measured at 517 nm, against a blank methanol without DPPH. 
Colour corrections were done by measuring the absorbance of the samples and 
solvents and its absorbance subtracted from the absorbance measured at the 
end of the assay. This was done to make sure that the absorbance of the 
samples does not interfere with the results. Results were expressed as IC50 
concentration where 50% inhibition of the DPPH radical was obtained. 
Percentage of inhibition of the DPPH was calculated following the equation: 
% inhibition of DPPH =  
 
where Abs control is the absorbance of DPPH solution without sample. 
Ascorbic acid was used as an antioxidant standard. 
  Abs control ± Abs sample 
            Abs control 
X 100 
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3.4.1.4  ȕ-carotene Bleaching assay 
7R HYDOXDWH WKH DQWLR[LGDQW DFWLYLW\ UHODWHG WR OLSLG SHUR[LGDWLRQV WKH ȕ-
carotene bleaching assay was applied with reference to Barreira (2008). A 
VROXWLRQRIȕ-caroteQHZDVSUHSDUHGE\GLVVROYLQJPJRIȕ-carotene in 10 mL 
of chloroform. 2 mL of this solution was pipetted into a 100 mL round bottom 
flask. Added into the round bottom flask were 40 mg of linoleic acid and 400 
mg of Tween 80 emulsifier. The chloroform was then removed using the rotary 
evaporator at 40 ϶C. After all the chloroform was removed, 100 mL of distilled 
water was added and the flask was then shake YLJRXURXVO\/RI WKHȕ-
carotene solution was transferred into each well containing 10 µL of sample.  
 
The t0 absorbance (absorbance at 0 min) was taken immediately after the plates 
were ready. Incubations were done at 50 ϶C for 4 hours or until the control 
sample had changed colour. A control well was prepared containing water and 
WKH ȕ-carotene solution only %ODQN GHYRLG RI ȕ-carotene were also prepared 
for each sample to correct for the colour of the sample. OxidDWLRQV RI ȕ-
carotene emulsion were monitored using a spectrophotometer by measuring the 
absorbance at 490 nm. Degradation rates were calculated according to the first-
order kinetics with reference to Mayachiew (2008) using the below formula: 
Sample degradation rate (DR) = ln a/b x 1/t,  
where a is the initial absorbance at t0; b is the absorbance at 240 min; t is time 
(min).   
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The antioxidant activities were expressed as % inhibition relative to the control 
using: 
Antioxidant activity =  
 
Results were expressed as EC50 concentration where 50 % degradation of the 
ȕ-carotene was obtained. 
 
3.4.1.5  Determination of total phenolic content  
Total phenolic contents of the fractions were determined using Folin-
Ciocalteau assay adapted from Singleton (1999) and Waterhouse (2001). Two 
µL of sample was mixed with water (158 µL) and Folin-Ciocalteau reagent (10 
µL) and left to stand for 8 minutes in room temperature before 30 µL of 
sodium carbonate solution was added in. This makes the total volume 200 µL. 
The solution was mixed and allowed to stand for 30 minutes in the water bath 
at 40϶ C. Then, the absorbance was recorded at 700 nm using the microplate 
reader. A calibration curve of gallic acid was also prepared starting with final 
concentration of 50 µg/mL and subsequent 2 fold dilution. Results were 
expressed as g of gallic acid equivalent (GAE)/100 g sample. 
 
 
 
 
DR Control ± DR Sample 
DR Control 
X 100 
  
118 
3.4.2 Cytotoxic and cytoprotective evaluation 
3.4.2.1 Cell culture 
All the cytotoxic and cytoprotection assays were executed with cell culture 
with the conditions as stated. HepG2 cells were grown to 90% confluence 
before seeding into 24 - well culture plates, and left overnight to adhere prior 
to treatment at 37qC in a 5 % CO2. Cells were grown in Minimum Essential 
Eagle medium with 10 % v/v foetal bovine serum (FBS), 1 % v/v non-essential 
amino acid solution, 2 µg/mL of fungizone and 0.05 mg/mL of gentamicin.  
 
3.4.2.2   Neutral red cytoprotection assay ± direct activity 
Cells were treated with the ethanol extract, the F5 fraction or quercetin at 
various concentrations for 5 hours, in the absence or presence of 0.5 mM t-
BHP, in medium containing 2 % v/v FBS. The medium was washed off, and 
replaced with complete medium containing neutral red at 20 µg/mL. Cells 
were incubated at 37qC for one hour. Medium was removed again and cells 
were washed with buffered saline prior to fixation of the cells with 
water:ethanol:glacial acetic acid (50:50:1 v/v). Plate was shaken on an orbital 
shaker for 10 mins to solubilize the cell-retained dye. Absorbances were taken 
at 540 nm, from which cell viability was calculated. 
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3.4.2.3   Neutral red cytoprotection assay ± indirect activity 
Cells were treated with the ethanol extract, the F5 fraction or quercetin at 
various concentrations for 20 hours in complete culture medium. The medium 
was removed and cells were exposed to 0.5 mM t-BHP in medium containing 
2 % v/v FBS for 5 hours. The medium was washed off, and replaced with 
complete medium containing neutral red at 20 µg/mL. Cells were incubated at 
37qC for one hour. Medium was removed again and cells are washed with 
buffered saline prior to fixation of the cells with water:ethanol:glacial acetic 
acid (50:50:1 v/v). Plate was shaken on orbital shaker for 10 mins to solubilize 
the cell retained dye. Absorbances were taken at 540 nm, from which cell 
viability was calculated. 
 
3.4.3 Antimicrobial screening 
3.4.3.1 Pour plate disc diffusion assay 
Samples were screened for their antibacterial activity using the disc diffusion 
assay of Kelmanson et al. (2000). Samples were dissolved in dimethyl 
sulfoxide (DMSO). The test microorganisms used were Gram-positive Bacillus 
cereus ATCC 11778, Bacillus subtilis ATCC 6633, Staphylococcus aureus 
ATCC 11632 and Methicillin resistant Staphylococcus aureus (MRSA) clinical 
strain and Gram-negative Escherichia coli ATCC 8739, Pseudomonas 
aeruginosa ATCC 10145, and Citrobacter freundii ATCC 8090. Bacteria were 
grown in Mueller-Hinton broth until specific optical density (OD) that will 
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give 1 x 108 bacteria/mL. Mueller-Hinton soft agar was prepared by using half 
of the amount of agar needed to prepare the Mueller-Hinton agar.  
 
Six mL of molten Mueller-Hinton soft agar inoculated with 100 µL of bacteria 
were poured on a prepared Mueller-Hinton agar plate and quickly swirled to 
get a confluent distribution of bacteria. Discs were prepared with 100 µg dose 
of samples and 5 µg of positive standard. Ampicillin and streptomycin were 
used as positive controls and DMSO as negative controls. Plates were 
incubated at 37 ϶C overnight. The antimicrobial activity was expressed as the 
mean diameter of the inhibition zone (mm) including diameter of disc (6 mm). 
Diameters were measured manually with a caliper. 
 
3.4.3.2 Determination of Minimum Inhibitory Concentration (MIC) and 
Minimum Bactericidal Concentration (MBC) 
Minimal inhibitory concentration (MIC) and bactericidal (MBC) concentration 
were determined for the samples showing antibacterial activity in the disc 
diffusion assay. These were determined by the microbroth dilution method as 
of Kelmanson et al. (2000) with modifications. The broth dilution method was 
employed on Gram-positive Bacillus cereus ATCC 11778, Bacillus subtilis 
ATCC 6633, Staphylococcus aureus ATCC 11632 and Methicillin resistant 
Staphylococcus aureus (MRSA) clinical strain. Two fold serial dilutions of the 
samples were used ranging from 3 mg/mL to 0.0234 mg/mL. Antibiotics used 
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were streptomycin (50-0.391 µg/mL) and ampicillin (100-0.781 µg/mL). MIC 
values were taken as the lowest concentration of samples that inhibited 
bacterial growth after 18 hours incubation at 37϶C. MBC were determined by 
dispensing 10 µL of the broth of the MIC concentration and plating on MHA 
plate. Plates with growth less than 10 colonies after 18 hours incubation were 
considered the bactericidal concentration.  
  
3.5 Chemical and Biological Assays on the Active Fraction 
 
3.5.1 HPLC profiling of F5 
Compounds in F5 were separated by HPLC with a Zorbax C18 column (4.6 mm 
x 150 mm, 5 µm particle size) from Agilent Technologies with the mobile 
phase gradient as in Table 3.1. Peaks were detected at dual wavelength, 254 
nm and 280 nm. The UV spectra of all the peaks were scanned using a PDA 
deWHFWRU WR LGHQWLI\ WKHȜ maximas of the compounds concurrently. Injection 
volume for analytical separation was 20 µL. 
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Table 3.1 Mobile phase gradient for analytical separations of F5. 
 
Time Flow rate 
Mobile phase A 
(Water) 
Mobile phase B 
(Acetonitrile) 
Prerun 1.0 90 10 
3.0 0.5 90 10 
35.0 0.5 60 40 
40.0 1.0 5 95 
43.0 1.0 5 95 
43.1 1.0 90 10 
48.0 1.0 90 10 
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3.5.2 Identification of the constituents in F5 by TOF-MS 
The identities of the compounds in F5 were screened by LC-MS profiling with 
Bruker MicroTOF II system. Sample was dissolved with 20 % acetonitrile and 
separation of the constituents was performed on a Zorbax C18 column (4.6 mm 
x 150 mm, 5 µm particle size) from Agilent Technologies with gradient 
acetonitrile and water mixtures. The peaks were detected at 280 nm. All the 
peaks were then diverted to the MS system and scanned from m/z 100 ± 1500 
for detection of the fragments. All MS analysis were performed in negative 
ionization mode. 
 
3.5.3 Isolation of the major constituent of F5 
Isolation of the major compound in F5 was done by up-scaling the HPLC 
system to a semi-preparative system by increasing the flow rate, detector flow 
cell and using a semi-preparative column (Zorbax SB-C18, 9.4 mm x 150 mm, 
5 µm particle size) from Agilent Technologies. The scale-up method is 
visualized in Table 3.2. The fraction collector was set to collect upon threshold 
at 0.5 mins for every tube. All the fractions collected were dried using a freeze 
drier for further analysis. Injection volume for semi-preparative separation was 
100 µL. 
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Table 3.2. Mobile phase gradient for scale-up semi preparative separations. 
 
Time Flow rate 
Mobile phase A 
(Water) 
Mobile phase B 
(Acetonitrile) 
Prerun 4.2 90 10 
3.0 2.1 90 10 
35.0 2.1 60 40 
40.0 4.2 5 95 
43.0 4.2 5 95 
43.1 4.2 90 10 
48.0 4.2 90 10 
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3.6. Formulation of F5 as a Topical Preparation 
 
3.6.1 Formulation of the topical preparation 
Three bases of formulations were prepared. The formulations used were: 
formulation 1 of soft paraffin base, formulation 2 of wool fat cream base and 
formulation 3 of liquid paraffin base. The excipients contained in each 
formulation with the percentage are detailed in Table 3.3. The tannin fractions 
were dissolved in the water percentages of the formulation at an MBC 
concentration. 18 mg of the tannin fraction (F5) were incorporated in 5 g of the 
cream bases prepared. The following commercial antibacterial products were 
used as positive control: Burnol® and Betadine®. The active ingredients in 
Burnol® are aminacrine HCl, cetrimide and thymol, where as in Betadine®, 
the active ingredient is providone iodine. The cream bases were used as 
negative controls (placebo). 
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Table 3.3. Excipients contained in the formulations 
Formulation Excipients Percentage (%) 
Formulation 1 Emulsifying wax  
Liquid paraffin 
White soft paraffin  
Water 
10 
10 
20 
60 
Formulation 2 Arachis oil 
Oleic acid 
Calcium hydroxide 
Wool fat 
Water 
32 
0.5 
0.045 
8 
100 
Formulation 3 Glycerol 
Sodium stearate  
Cetostearyl alcohol 
Liquid paraffin 
Water 
5 
3 
2 
25 
65 
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3.6.2  Efficacy of the topical preparations in-vitro on Staphylococcus aureus 
The formulations were tested with the pour plate well diffusion assay. Bacteria 
were grown in Mueller-Hinton broth until specific optical density (OD) that 
gave 1 x 108 cfu/mL. 6 mL of molten Mueller-Hinton soft agar inoculated with 
100 µL of bacteria were poured on Mueller-Hinton agar plate and quickly 
swirled to get an even distribution of bacteria. 5 mm wells were made with a 
cork borer and the formulations were dispensed into the well using a Luer-slip 
1 mL syringe. Volume of formulation dispensed into each well was 50 µL. 
Plates were incubated at 37 ϶C overnight. The antimicrobial activity was 
expressed as the mean diameter of the inhibition zone (mm).  
 
3.6.3 Efficacy of Formulation 1 on Staphylococcus aureus 
The pour plate well diffusion assay was performed as previously described in 
3.6.2, with repetitions on day 1, 3, 5, 7 and 10 after the formulation was 
prepared, to observe the effectiveness of the formulation throughout 10 days. 
Results were measured as the mean diameter of inhibition in mm.  
 
3.6.4 In vivo study of the topical formulation on guinea pigs 
The antibacterial property of the formulation was assessed by in vivo 
colonization. Guinea pigs were anesthetized by diethyl ether prior experiment. 
The back of the guinea pigs were clipped free of fur (2 cm x 2 cm) and 
swabbed with 70 % ethanol. A cut was made on the skin and infected with the 
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bacterial inoculum of Staphylococcus aureus (50 µL). The infections on the 
guinea pigs were observed for 2 days. On the 3rd day, the infected areas were 
administered with the formulation containing the active fraction, placebo 
formulation, a positive standard (Burnol®) and one patch are left untreated (six 
guinea pigs per group). Treatments lasted for 10 days and data were collected 
on the 11th day. The number of viable organisms was determined by the 
swabbing method as described by Rubinchik et al. (2009). Colony counts were 
determined by swabbing the infected area with a sterile cotton-tip. The 
sampling solutions were then further diluted and plated for colony counts 
(Rubinchik et al., 2009). 
 
3.7 Synergistic Studies of the Active Fraction F5 with Antibiotics  
 
3.7.1 Checkerboard assay 
To evaluate presence of synergism or antagonism of the samples with 
antibiotics, isobolograph analyses were done applying the checkerboard assay 
with reference to White et al., (1996) and Tallarida (2001). This method 
involves varying the concentrations of the samples and the antibiotics along 
different axes ensuring that each well contained different combinations of the 
samples and the antibiotics as in Figure 3.1. 
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The antibiotics used were Ampicillin, Tetracycline and Streptomycin. The 
analyses were performed in 96 well plates. Bacteria were grown to reach 
optical density as of 2 x 108 cfu/mL. 5 microliters of the inoculums were added 
into the well containing samples, antibiotics and MHB. Total volume in each 
well was 200 µL. 
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Figure 3.1. Layout of the 96-well plate for the execution of the Checkerboard 
assay 
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The plates were incubated for 18 hours at 37 ϶C. MIC of the combination was 
determined as the lowest concentration which completely inhibited bacterial 
growth. To evaluate the effect of the combinations, fractional inhibitory 
concentration (FIC) were calculated for each combination using the following 
formula: 
FICA = MICA in combination/MICA alone 
FICB = MICB in combination/MICB alone 
FIC index = FICA + FICB 
FICA is the FIC of the antibiotic, MICA is the MIC of the antibiotic, FICB is the 
FIC of the sample and MICB is the MIC of the sample. FIC index is the FIC 
added value of both the antibiotic and the samples. The interaction of the 
antimicrobial combinations was determined by plotting an isobologram as 
previously reported by Mandalari et al. (2010) and Jayaraman et al. (2010). 
 
3.7.2  Time-kill assay 
The time-kill method to analyze synergism follows the same procedure in the 
microbroth dilution of the MIC determination. Different combinations of 
samples and antibiotics were added into different wells. The optical density of 
the plates was observed at 600 nm with a microplate reader every 1 hr for 18 
hrs. The absorbance were plotted to define the growth curve of each 
combination. The curves of the sample alone, antibiotics alone and the 
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combination were compared to assess viable colony counts against time 
(Tallarida 2001).  
 
3.8 FESEM Analysis on Cell Membrane Integrity of Staphylococcus 
aureus and Methicilin resistant Staphylococcus aureus (MRSA) 
 
FESEM analysis was conducted to observe the morphology of bacteria cells 
upon treatment with the ethanol extract and F5. A high resolution FESEM was 
used (FEI Quanta 400). Untreated bacteria cells were used as controls. 
Staphylococcus aureus and Methicilin resistant Staphylococcus aureus were 
cultured overnight in MHB at 37 ϶C. Cells were treated with the MIC dose of 
the samples, and left again overnight. It is then harvested by centrifugation at 
5000 rpm for 10 mins. Cells were washed twice with 0.1M phosphate buffer 
(pH 7.2) and fixation was done by immersing the cells in 2.5 % formaldehyde 
overnight at 4 ϶C. After fixation, cells were washed again with phosphate 
buffer twice before serially dehydrated with increasing ethanol water mixtures 
(30 % - 100 %) for 10 minutes each gradient. Cells were left in 100 % ethanol 
to mount on the metal stubs for viewing. 
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CHAPTER 4 
RESULTS 
_______________________________________________________________ 
 
4.1 Plant Collection and Extraction 
 
Acalypha wilkesiana var. macafeana hort. was collected and authenticated by 
the Forest Research Institute Malaysia (FRIM). Voucher specimens were 
pressed and deposited at the School of Pharmacy, The University of 
Nottingham Malaysia Campus (UNMC 9W). The percentage yields of extracts 
are expressed as per dry weight of plant material (Table 4.1). The highest 
percentage yield was obtained from extraction with water, while the least is 
from ethyl acetate. Percentage yield was calculated per dry weight of the 
grinded plant material. 
 
4.2 Fractionation of the Ethanol Extract 
 
The ethanol extract was chosen to be separated further via chromatography as 
it was the active extract for both antioxidant and antibacterial screening. The 
ethanol extract was separated through Sephadex LH-20 column and 5 fractions 
were afforded with the yield of the fractions as in Table 4.2. The fractionation 
progress was captured in Figure 4.1. Percentage yield was calculated as per dry 
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ethanol extract used for fractionation. All fractions were obtained as solid 
materials except for F1 which was in sticky liquid form.  The highest yield was 
obtained from fractionation with 25 % aqueous ethanol. 
 
4.3 Antioxidant Properties of Fractions 
 
Qualitative assessment with DPPH spray on the TLC chromatographic profiles 
of the fractions showed long tailing bands of yellow shade, which did not 
specifically show the antioxidant active compound or fraction as pictured in 
Figure 4.2. This emphasizes the importance for evaluation to be done 
quantitatively. To evaluate quantitatively the antioxidant potential of the 
ethanol extract of A. wilkesiana var. macafeana KRUW DQG LWV¶ IUDFWLRQV Whree 
antioxidant tests were performed i.e., FRAP assay, DPPH radical scavenging 
DVVD\DQGȕ-carotene bleaching assay. Results are presented in Table 4.3. The 
total phenolic content of the samples was also assessed with Folin-Ciocalteau 
reagent, and the results are presented in Figure 4.3. 
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Figure 4.1. Process of fractionation with Sephadex LH-20. (Picture from left to right). 
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Table 4.1 Yield of extraction and form of each extract. 
 
Extract Yield (%) Form 
Hexane 0.32 Sticky dark brown liquid 
Ethyl acetate 0.18 Sticky dark green liquid 
Ethanol 3.29 Dark red solid 
Water 15.84 Dark brown solid 
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Table 4.2 Yield of fractionation and form of each fraction. 
 
Fraction Form Solvent Yield (%) 
F1 Dark yellow sticky liquid 25 % aq. Ethanol 18.9 
F2 Dark red solid 50 % aq. Ethanol 17.6 
F3 Dark purple solid 75 % aq. Ethanol 12.4 
F4 Dark purple solid 100 % Ethanol 15.2 
F5 Dark brown/golden solid 70 % aq. Acetone 17.9 
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Interestingly, our research showed that F5 displayed the most prominent 
antioxidant effect in all three assays as compared to other fractions and the 
crude ethanol extract with antioxidant capacity of 2.090 ± 0.307 µg/mL, 0.532 
± 0.041 µg/mL, 0.032 ± 0.025 µg/mL in FRAP, DPPH and BCB assay, 
respectively. Additionally, F5 was more active than positive standards used in 
the three assays i.e., quercetin, Trolox and ascorbic acid. The total phenolic 
content for F1 and F5 were significantly higher than the ethanol extract with 
values equal to 208.7 ± 7.02, 179.57 ± 17.96 g of gallic acid equivalent/100 g 
sample, respectively. Clear correlation is seen between the antioxidant 
potentials and the total phenolic content, thus suggesting that the phenolics 
account for antioxidant activity of the plant. 
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Figure 4.2 Thin Layer Chromatography (TLC) plates sprayed with DPPH spray which results in yellow 
tailing bands of antioxidant bioactives in purple background. 
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Table 4. 3 Antioxidant properties of samples evaluated with FRAP, DPPH and BCB assay. 
 
Sample 
FRAP DPPH BCB 
FE (µg/mL) IC50 (µg/mL) EC50(µg/mL) 
Mean ± SEM 
Crude Ethanol 10.613 ± 2.643 1.172 ± 0.834 0.122 ± 0.039 
F1 2.660 ± 0.510 1.048 ± 0.085 0.082 ± 0.026 
F2 7.604 ± 0.113 1.222 ± 0.183 0.194 ± 0.132 
F3 6.670 ± 0.383 0.902 ± 0.291 0.401 ± 0.445 
F4 5.018 ± 0.788 1.482 ± 0.139 0.089 ± 0.086 
F5 2.090 ± 0.307 0.532 ± 0.041 0.032 ± 0.025 
Trolox  8.422 ± 0.897 Nd 0.120 ± 0.081 
Quercetin 3.072 ± 0.436 Nd 0.266 ± 0.177 
Ascorbic acid Nd 1.181 ± 0.223 Nd 
*Nd: Not determined. 
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Figure 4.3. Total phenolic content of the fractions. Each bar represents mean ± 
SEM of three independent experiments. (* shows significance at p < 0.05 vs. 
ethanol extract). 
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4.4  Antibacterial Properties of Fractions 
 
The hexane, ethyl acetate and ethanol extracts (100 µg) of A. wilkesiana var. 
macafeana hort. were tested against gram-positive Bacillus cereus (ATCC 
11778), Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 11632) 
and Methicillin resistant Staphylococcus aureus (MRSA) clinical strain and 
gram-negative Escherichia coli (ATCC 8739), Pseudomonas aeruginosa 
(ATCC 10145), and Citrobacter freundii (ATCC 8090). As shown in Table 
4.4, noticeable antibacterial activities were observed with the ethyl acetate and 
ethanol extract whereby the hexane extract was inactive. The inhibition zone 
diameters of the ethyl acetate and ethanol extracts were equal to 8.06 ± 0.32 
mm and 9.36 ± 1.22 mm against B. subtilis (ATCC 6633), and 8.42 ± 0.58 mm 
and 8.73 ± 0.92 mm against S. aureus (ATCC 11632), respectively.  
 
Interestingly, the ethyl acetate and ethanol extract (100 µg) inhibited the 
growth of MRSA with inhibition diameters equal to 7.20 ± 0.94 and 7.31 ± 
0.38 mm, respectively. Both antibiotics used at a dose of 5 µg were inactive 
against MRSA.  Both ethyl acetate and ethanol extract incurred partial 
inhibition zones against gram-negative E. coli (ATCC 8739) with inhibition 
diameters equal to 8.13 ± 0.94 mm and 13.48 ± 0.10 mm, respectively. Partial 
inhibition is noted if there are resistant colonies growing on the inhibition 
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zones. The ethanol extract expressed the highest antibacterial activity and 
account for the antibacterial properties of A. wilkesiana var. macafeana hort. 
 
To further locate the active constituents, the ethanol extract was passed 
through a Sephadex LH-20 column affording 5 fractions. The antibacterial 
potencies of the 5 fractions were tested with the pour plate disc diffusion assay 
against gram-positive Bacillus cereus (ATCC 11778), Bacillus subtilis (ATCC 
6633), Staphylococcus aureus (ATCC 11632) and Methicillin-resistant 
Staphylococcus aureus (MRSA) clinical strain and gram-negative Escherichia 
coli (ATCC 8739), Pseudomonas aeruginosa (ATCC 10145), and Citrobacter 
freundii (ATCC 8090)  (Table 4.5).  
 
After the incubation, the highest antibacterial activity was elicited by the fifth 
fraction (F5) with inhibition zones equal to 11.01 ± 1.53 mm, 16.63 ± 0.11 
mm, 11.40 ± 1.10 mm and 8.22 ± 0.19 mm in Bacillus cereus (ATCC 11778), 
Bacillus subtilis (ATCC 6633), Staphylococcus aureus (ATCC 11632) and 
MRSA (clinical strain) respectively. Ampicillin and streptomycin were 
inactive at a dose of 5 µg against MRSA whereas F5 was active against all the 
gram-positive bacteria. F5 is the last fraction eluted with aqueous acetone from 
Sephadex LH-20 column implies the fact that it consists of high molecular 
weight molecule (Hagerman 2002). 
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Table 4.4 Diameter inhibition of extracts.  
 
  
Sample 
Inhibition diameter (mm, SD) 
Gram positive   Gram negative (partial inhibition) 
B. cereus B. subtilis S. aureus MRSA E. coli P. aeruginosa C. freundii 
Hexane NI NI NI NI NI NI NI 
Ethyl Acetate 8.06 ± 0.32 8.14 ± 0.42 8.42 ± 0.58 7.20 ±0.26 8.13 ± 0.94 NI 9.56 ± 1.20 
Ethanol 9.36 ± 1.22 14.22 ± 0.13 8.73 ± 0.92 7.31 ±0.38 13.48 ± 0.10 NI 12.82 ± 3.52 
Ampicillin 8.12 ± 1.26 NI 15.19 ± 0.62 NI 11.95 ± 0.70 NI NI 
Streptomycin 12.31 ± 1.64 13.77 ± 0.48 10.44 ± 0.40 NI 10.84 ± 0.51 NI 14.32 ± 1.47 
DMSO NI NI NI NI NI NI NI 
* NI - no inhibition observed. Doses of the samples were 100 µg per disc while for antibiotics were 5 µg per disc. 
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Table 4.5 Inhibition diameters of fractions from the ethanol extract. 
 
  
Sample 
Inhibition diameter (mm, SD) 
Gram positive Gram negative (partial inhibition) 
B. cereus B. subtilis S. aureus MRSA E. coli P. aeruginosa C. freundii 
Crude Extract 9.36 ± 1.22 14.22 ± 0.13 8.73 ± 0.92 7.31 ±0.38 13.48 ± 0.10 NI 12.82 ± 3.52 
F1 NI NI NI NI NI NI NI 
F2 6.68 ± 0.63 NI NI NI NI NI NI 
F3 7.18 ± 0.71 14.52 ± 0.28 7.30 ± 0.15 NI NI NI NI 
F4 10.47 ± 0.85 16.40 ± 0.01 9.60 ± 1.10 NI 14.83 ± 0.04 NI NI 
F5 11.01 ± 1.53 16.63 ± 0.11 11.40 ± 1.10 8.22 ±0.19 15.28 ± 0.70 9.98 ± 2.46 13.74 ± 3.52 
Ampicillin 8.12 ± 1.26 NI 15.19 ± 0.62 NI 11.95 ± 0.70 NI NI 
Streptomycin 12.31 ± 1.64 13.77 ± 0.48 10.44 ± 0.40 NI 10.84 ± 0.51 NI 14.32 ± 1.47 
DMSO NI NI NI NI NI NI NI 
* NI - no inhibition observed. Doses of the samples were 100 µg per disc while for antibiotics were 5 µg per disc. 
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We raised the question of whether F5 treatment affects the survival or division 
of bacteria and therefore determined the minimum inhibitory concentration 
(MIC) of F5 and observed that F5 inhibited bacterial multiplication of MRSA 
at concentration of 750 µg/mL. Bactericidal effects against S. aureus (ATCC 
11632) and MRSA were evidenced with the minimum bactericidal 
concentration (MBC) assay which yielded a MBC value equal to 3 mg/mL 
(Table 4.6). 
 
4.6  Identification of Constituents in F5 
 
The identity of the compounds in F5 was identified by fragmentations of the 
compounds via Bruker MicroTOF II MS system. Sample was dissolved with 
20 % acetonitrile and separation of the constituents was performed on a Zorbax 
C18 column (4.6 mm x 150 mm, 5 µm particle size) from Agilent Technologies 
with gradient acetonitrile and water mixtures. The peaks were detected at 280 
nm as this wavelength is the wavelength for detection of tannins. All the peaks 
were then diverted to the MS system and scanned from m/z 100 ± 1500 for 
detection of the fragments. All MS analysis was performed in negative 
ionization. HPLC profiling of the active fraction F5 were optimized in 
analytical scale and were performed before any MS analysis were done. HPLC 
chromatographic profile is captured in Figure 4.4. 
  
147
 
Table 4.6. MIC and MBC 
 
Sample 
MIC (µg/mL) MBC (µg/mL) 
S. aureus B. cereus MRSA S. aureus B. cereus MRSA 
Crude extract 1500 3000 1500 3000 >3000 3000 
F5 750 3000 750 3000 >3000 3000 
Ampicillin 50 3.125 > 100 50 3.125 >200 
Streptomycin 1.563 0.391 100 1.563 0.391 >100 
Tetracycline 0.625 Nd > 20 0.625 Nd > 20 
                          * Nd: Not determined 
.
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 To gain further insights to the nature of active constituents of F5 liquid 
chromatography/mass-spectrometry (LC/MS) analysis was performed allowing 
the identification of a major tannin. The major tannin (2) was identified as 
geraniin (54.9 %) in line with evidence provided by Self et al. (1986). 
Percentage of other compounds in F5 was in the range of 0.2 % to 5 %. The 
resulting chromatogram is shown in Figure 4.4. Geraniin forms an equilibrium 
mixture of a hydrated five-membered hemiacetal ring structure and a hydrated 
six-membered hemiacetal-ring upon mutarotation (Okuda et al., 1982).  
 
Other compounds present in F5 were also analyzed using their fragmentation 
patterns as tabulated in Table 4.7 and referenced to the literature. LC-MS/MS 
method was needed to distinguish between presence of quercetin or ellagic 
acid as both compounds produce molecular ions of [M-H] m/z 301 (Mullen et 
al., 2003). MS/MS analysis showed that further fragmentation of m/z 301 
yielded characteristic daughter ions of m/z 257 and 229 which is the unique 
pattern for ellagic acid (Seeram et al., 2006). All of the peaks except peak (1) 
and (7), yielded a fragment of m/z 301, and showed the same daughter ion 
fragments, thus confirming that the peaks are ellagitannins.  
 
Peak (1) LV ȕ-D-glucogalline which yields ion fragments of m/z 331 and 169 
(Figure 4.7) with the same respective fragments identified by Pawlowska et al. 
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(2010). The fragments that we propose to justify the fragmentation are shown 
in Figure 4.8.  ȕ-D-glucogalline is a simple gallotannin which comprises of 
JDOOLFDFLGDQGDȕ-D-glucose. Peak (4) fragments were referenced to Hager et 
al. (2008) as fragmentation ions yield upon MS were m/z 935 and m/z 301 
(Figure 4.9) and was identified as Potentillin. The fragment at m/z 301 is 
ellagic acid. The fragmentation proposed to justify for the fragmentations are 
represented in Figure 4.10. Peak (7) showed a m/z 935.0 (Figure 4.11) which 
was shown to be double charged [M-2H]2- by zoom scan analysis giving its 
real m/z as 1870 for the peak as referenced in Hager et al. (2008) as sanguiin 
H-6 or lambertianin A. The zoom scan analysis spectrum is shown as Figure 
4.12.  
 
The major compound geraniin (2) was then isolated and freeze dried before 
analysis with NMR to elucidate. Samples were able to be isolated in the pure 
form enough for only NMR analysis. Further experiments with the pure form 
of geraniin were not able to be executed due to the quantity of the pure 
Geraniin isolated. NMR analysis interpreted as shift of 1H NMR and 13C NMR 
are tabulated in Table 4.8 and Table 4.9 with comparison to existing literature. 
The comparison shows that the identification of the compound is geraniin, in 
correspondence with findings by LC-MS. Geraniin forms an equilibrium 
mixture of 2a and 2b in an aqueous solution (Okuda et al., 1982). Upon 
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equilibration, each carbon shows two peaks in the 13C NMR spectra at a ratio 
of 1:1 (Appendix). 
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Figure 4.4. Chromatographic profile of F5. (HPLC ) 
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Figure 4.5. LC-MS spectra of Compound 1 
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Figure 4.6. Fragments proposed to justify fragmentation observed in mass 
spectrum of compound 1 (ȕ-D-glucogalline). 
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Figure 4.7. LC-MS spectra of Compound 2 
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 (Continued) 
 
Figure 4.8. Fragments proposed to justify fragmentation observed in mass 
spectrum of compound 2 (Geraniin). 
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Figure 4.9. LC-MS spectra of Compound 4 
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Figure 4.10. Fragments proposed to justify fragmentation observed in mass 
spectrum of Compound 4 (Potentillin). 
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Figure 4.11. LC-MS spectra of Compound 7 
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Figure 4.12. Doubly charged peak at m/z 935 (zoom scan analysis) 
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(Continued) 
 
 
Figure 4.13. Fragments proposed to justify fragmentation observed in mass 
spectrum Compound 7 (Sanguiin H-6) 
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Table 4.7. Summary of fragments identified by LC-MS. 
No. Rt 
(min) 
% m/z MS/MS breakdown Compound Ref. 
1 1.8 0.2 331.1 169.0 ȕ-glucogallin  Pawlowska et al., 
2006 
2 26.5 54.9 951.1 633.1, 466.0 , 301.0, 169.0 Geraniin Self et al., 2010 
3 28.5 3.0 1109.1 933.1, 554.0, 467.0, 301.0, 175.0 Unidentified 
ellagitannin 
None 
4 31.0 5.9 935.1 301.0 Potentillin Hager et al., 2008 
5 32.0 3.7 1890.1 935.1, 769.1, 301.0 Unidentified 
ellagitannin 
None 
6 34.8 4.2 1890.1 935.1, 769.1, 633.1, 301.0 Unidentified 
ellagitannin 
None 
7 36.0 4.2 935 (doubly 
charged) 
1870.2 
541.0, 458.0 Sanguiin H-6 Clifford & 
Scalbert, 2000 
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Table 4.8. 1H-NMR data of compound 2 in acetone-d6 plus D2O (referenced relative to solvent peak = 2.05 ppm) with 
comparison to existing literature (Apendix: NMR spectra of compound 2). 
Moiety H 
NMR shifts 
1 a (Ref1) Current work 1b (Ref2) Current work 
Glucose H-1 6.17 (dd, J = 1.2, 1.6) 6.55 (t J= ca. 1.1)  6.53 (t J= ca. 1.1) 
 H-2 5.57 (dt, J = 1.2, 2.4) 5.55 (m)  5.54 (m) 
 H-3 5.48 (ddd, J = 1.6, 2.4, 4) 5.39 (m)  5.51 (m) 
 H-4 5.53 (br dd, J = 1.2, 4) 5.50 (m)  5.39 (m) 
 H-5 4.80 (br ddd, J = 1.2, 8, 11)  4.81 (m)  4.79 (m) 
 H-6 4.32 (dd, J = 8, 11) 4.31 (m)  4.40 (m) 
 H-¶ 4.93 (t, J = 11) 4.82 (m)  4.70 (m) 
Ring B H-1 5.18 (s) 5.15 (s) 4.72 (d) 4.89 (d, J= 1.4) 
 H-3 6.53 (s) 6.48 (s) 6.26 (d) 6.21 (d, J=1.4) 
Galloyl 3  7.03 (s) 7.15 (s)  7.14 (s) 
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HHDP 3  6.49 (s) 7.07 (s)  7.02 (s) 
  6.58 (s) 6.63 (s)  6.62 (s) 
Ring A H-2  7.17 (s)  7.21 s) 
 
1. Okuda et al. (1986). 
2. Okuda et al. (1982). 
3. Nawwar et al. (1994).
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Table 4.9. 13C-NMR data of compound 2 in acetone-d6 plus D2O (referenced relative to solvent peak = 29.92 
ppm) with comparison to existing literature. (Appendix: NMR spectra of compound 2). 
Moiety C 
NMR shifts 
1 a (Ref1) Current work 1b (Ref1) Current work 
Glucose C-1 90.81 91.07 91.76 91.90 
 C-2 69.89 70.05 70.37 70.65 
 C-3 63.27 63.36 62.28 62.40 
 C-4 65.85 65.90 66.78 66.84 
 C-5 72.55 72.61 73.14 73.22 
 C-6 63.64 63.68 63.80 63.92 
Ring B  C-1 46.05 45.92 51.89 51.84 
 C-2 154.32 154.20 149.09 148.98 
 C-3 128.59 128.74 125.01 125.34 
 C-4 191.73 192.04 194.80 194.88 
 C-5 96.14 96.25 92.37 92.42 
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 C-6 92.37 92.19 108.00 108.92 
 C=O  165.86a  165.72a 
Galloyl 3 1 118.7 119.82  118.88 
 2,6 109.0 110.46  110.64 
 3,5 145.6 145.98  140.61 
 4 139.0 140.13  140.05 
 C=O 164.9 165.55a  165.36a 
HHDP 3 ¶ 123.0, 123.9 124. 11b, 125.21b  124.26b, 125.62b 
 ¶ 106.1, 106.9 109.58, 107.66c  110.19, 107.55c 
 ¶ 
¶ 
143.9, 144.2,  
144.8, 144.9 
144.66d, 145.45d  144.95d, 145.18d 
 ¶ 135.4, 135.6 137.83, 136.35  137.59e, 136.32 
 ¶ 115.6, 115.8 117.39, 115.33  117.32, 115.24 
 C=O 166.8, 167.3 166.39, 168.74  166.38, 168.77 
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Ring A 1  115.69  119.82 
 2  119.82  116.24 
 3  113.48  113.37 
 4  145.79  147.72 
 5  139.24  137.76e 
 6  143.27  147.04  
 C=O  165.30a  164.92a 
 
1. Okuda et al. (1986). 
2. Okuda et al. (1982). 
3. Nawwar et al. (1994). 
x a, b, c, d, e: Shifts are interchangeable between each other. 
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 (a) (b) 
Figure 4.14. Major compound in F5: Compound 2 (Geraniin); equilibrium mixture of (a) and (b) upon mutarotation of the 
HHDP moiety in aqueous solution.  
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4.7  Cytotoxicity and Cytoprotection of F5 Against HepG2 Cell Lines 
 
The potential cytoprotective effects of both the ethanol extract and F5 against 
cell death induced by t-BHP were evaluated in HepG2 cells. EC50 values for 
cytoprotection of the ethanol extract, F5 and quercetin both for the direct 
activity and indirect activity are tabulated in Table 4.10. From the EC50 values, 
it can be concluded that both ethanol extract and F5 are less active than 
quercetin in both of the analysis with F5 being 7-fold and 3-fold less active 
than quercetin in the direct and indirect assay, respectively. Viability of HepG2 
cells exposed to 100 µg/mL of quercetin was reduced to 62.7 % in the direct 
assay (Figure 4.15c). Both the ethanol extract and F5 were non-toxic alone in 
all the concentration tested (6.25 ± 100 µg/mL) and also protected the cells 
against cell death in a dose-dependent manner, with F5 being more potent than 
the ethanol extract (Figure 4.15a and 4.15b).  
 
However, in the indirect cytoprotection assay, it was observed that quercetin 
was not toxic to the cells at the highest concentration (100 µg/mL) under the 
experimental protocol adopted (Figure 4.16c). Quercetin protected against t-
BHP toxicity, with less potency than in the direct activity assay with cell 
viability of 98.0 % with treatment of 100 µg/mL. Both the ethanol extract and 
F5 were also non-toxic to cells alone. They also protected the cells against 
insults induced by t-BHP, with F5 being more potent than the ethanol extract. 
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Cell viability after being induced by t-BHP was observed at 43.6 % and 82.7 % 
with protection from 100 µg/mL of the ethanol extract and F5, respectively 
(Figure 4.16a and 4.16b).  
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Table 4.10. EC50 values of cytoprotection activity of the ethanol extract, F5 
and quercetin 
 
Sample 
Direct activity (µg/mL) 
Indirect activity 
(µg/mL) 
Mean ± SEM 
Ethanol extract 89.1 ± 9.2 > 100 
F5 46.5 ± 12.0 66.0 ± 7.6 
Quercetin 6.6 ± 2.4 19.5 ± 0.2 
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Figure 4.15. Direct cytoprotection activity of the (a) ethanol extract, (b) F5 and 
(c) quercetin on t-BHP induced HepG2 cells. 
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Figure 4.16. Indirect cytoprotection activity of the (a) ethanol extract, (b) F5 
and (c) quercetin on t-BHP induced HepG2 cells. 
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4.8 Surface Morphology of Staphylococcus aureus by Field Emission 
Scanning Electron Microscopy (FESEM) 
 
To illustrate surface morphology of the bacterial cell wall upon treatment with 
the samples, FESEM analysis were performed on Staphylococcus aureus 
(ATCC 11632) and MRSA. The control cells without any treatments were full 
and smooth on the surfaces, as cell walls are undisrupted and well formed 
(Figure 4.17). Treatments with the MIC dose of the ethanol extract (1500 
µg/mL) disrupted the cell wall integrity of Staphylococcus aureus as surface 
deformation was observed (Figure 4.18). MRSA cells were observed adhering 
to each other with biofilm forming on the cells suggesting that some amounts 
of intracellular materials are released as observed in Li et al. (2011). Total 
collapse and broken cells were observed with the treatment with MIC dose of 
F5 on both S. aureus (ATCC 11632) and MRSA, as cell debris and indentation 
of the cell surface were seen (Figure 4.19). This suggests total lysis of the 
bacteria leading to bacterial death. 
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Figure 4.17. Morphology of the cells observed with FESEM of control (in MHB, without any treatment). Left: 
Staphylococcus aureus, Right: Methicillin Resistant Staphylococcus aureus. (Magnification: 30000x) 
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Figure 4.18. Morphology of the cells observed with FESEM after treatment with ethanol extract of Acalypha wilkesiana var. 
macafeana hort.. Left: Staphylococcus aureus, Right: Methicillin Resistant Staphylococcus aureus. (Magnification: 30000x) 
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Figure 4.19. Morphology of the cells observed with FESEM after treatment with F5 from Acalypha wilkesiana var. 
macafeana hort. Left: Staphylococcus aureus, (Magnification: 16000x) Right: Methicillin Resistant Staphylococcus aureus. 
(Magnification: 30000x)
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4.9  Synergistic Studies with Antibiotics against Staphylococcus aureus 
 
To get a better understanding of the mechanism underlying the bactericidal 
activity of F5, we examined the effect of F5 with 3 antibiotics i.e., ampicillin, 
tetracycline and streptomycin via the checkerboard assay and time-kill assay.   
Results obtained indicated that the F5 was synergistic with ampicillin (Figure 
4.20b) against Gram-positive Staphylococcus aureus (ATCC 11632) as 
represented by a convex line extrapolated from all the doses tested in the 
checkerboard assay. However, no synergy was observed between F5 and 
streptomycin (Figure 4.20a) and between F5 and tetracycline (Figure 4.20c) as 
additive relation was observed. 
 
The bactericidal effect of F5 was further assessed in the time-kill assay 
whereby combining ¼ MIC of ampicillin (12.5 µg/mL) with ½ MIC 
concentration of F5 (375 µg/mL) inhibited the growth of Staphylococcus 
aureus (Figure 4.21b). The synergy effect was further evidenced by the fact 
that ¼ of MIC concentration of ampicillin alone and ½ MIC concentration of 
F5 alone were inactive. In brief, ampicillin and F5 work synergistically to 
inhibit Staphylococcus aureus (ATCC 11632).  The combination of F5 and 
streptomycin (Figure 4.21a) was not boosting the bactericidal potencies of F5. 
Likewise with tetracycline (Figure 4.21c), as the combination, F5 alone and 
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tetracycline alone produces growth curves that are very similar. In conclusion, 
F5 is specifically synergistic with ampicillin. 
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Figure 4.20 (a). Isobologram of Streptomycin in combination with F5 which 
shows additive interaction. 
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Figure 4.20 (b). Isobologram of Ampicillin in combination with F5 which 
shows synergy interaction. 
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Figure 4.20 (c). Isobologram of Tetracycline in combination with F5 which 
shows additive interaction. 
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Figure 4.21 (a). Graph showing time-kill curves of combination of 
Streptomycin with F5 against Staphylococcus aureus (ATCC 11632). 
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Figure 4.21 (b). Graph showing time-kill curves of combination of Ampicillin 
with F5 against Staphylococcus aureus (ATCC 11632). 
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Figure. 4.21 (c). Graph showing time-kill curves of combination of 
Tetracycline with F5 against Staphylococcus aureus (ATCC 11632). 
 
 187 
4.10  Formulation of F5 as a Topical Antibacterial Formulation 
 
Three formulations were assessed for the antibacterial properties by the pour 
plate well diffusion test against Staphylococcus aureus (ATCC 11632). The 
pour plate well diffusion test provides a reliable and standardized method to 
assess the antibacterial activity of creams, ointments and formulations of anti-
infectives against bacteria strains (Rodeheaver et al., 1980; Conly et al., 1985; 
Ordoñez et al., 2009). As shown in Table 4.11, noticeable antibacterial 
activities were observed with formulation 1 with inhibition zone diameters of 
9.01 ± 0.14 mm. No inhibition was observed with the other two formulations. 
Formulation 1 consisted of 60 % water with a white soft paraffin and liquid 
paraffin base.  
 
The efficacy of the active tannin compounds in the formulation was observed 
as the test was repeated until day 10 after the formulation was prepared. As for 
the 10 days, the same antibacterial potencies were observed from formulation 
1. Indeed, the inhibition diameters observed were 10.05 ± 0.46 mm, 9.39 ± 
0.22 mm, and 9.17 ± 0.96 mm, respectively for day 3, day 7 and day 10. This 
was likewise observed with the anti-infective Betadine® and Burnol® which 
were used as positive control. 
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Table 4.11. In-vitro plate inhibition zones of formulation  
 
 Sample 
 
Inhibition zones (mm ) 
Day 1 Day 3 Day 7 Day 10 
Formulation 1 9.01 ± 0.14 10.05 ± 0.46 9.39 ± 0.22 9.17 ± 0.96 
Placebo 1 NI NI NI NI 
Formulation 2 NI NI NI NI 
Placebo 2 NI NI NI NI 
Formulation 3 NI NI NI NI 
Placebo 3 NI NI NI NI 
Betadine® 13.01 ± 0.42 14.06 ± 0.36 12.81 ± 0.37 14.35 ± 0.56 
Burnol® 12.18 ± 0.46 11.86 ± 0.34  11.87 ± 0.34   11.42 ± 0.33 
* NI: No inhibition observed. 
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4.11 In vivo Assessment of the Formulation against Skin Infection of 
Staphylococcus aureus on Guinea Pigs 
 
To further assess the effectiveness of the formulation against Staphylococcus 
aureus infections, the formulation (dose) were tested in vivo on guinea pigs 
that were infected with the afore mentioned bacterium. The viable colony 
counts 10 days post infection are tabulated in Table 4.12 and the wound 
healing properties are captured in Figures 4.22 (a-c). Viable colony counts 
after treatments shows that colonies from wounds with treatment of 
formulation 1 is less than wounds without treatment and treatment with 
placebo, but wounds with treatment with Burnol® was with the least viable 
colony. Although the viable counts show a reduction with treatment of 
formulation 1, the wound that was infected with the bacterium and did not 
receive any treatment, did not show any symptoms that were common with 
Staphylococcus aureus infections such as formation of blisters containing 
abscess, red blistering breaks and formation of crusts.   
 
As for the wound healing ability of the formulation, it is observed as illustrated 
in Figure 4.22 (a-c), that the wound with treatment with formulation 1 healed 
faster than wounds that were treated with both Burnol® and placebo. 
Formulation 1 promoted effective wound healing property than Burnol® 
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suggesting that the tannins (the active ingredient) plays a role in this instance. 
This would suggest that the antioxidant property of the formulation plays a role 
in the wound healing ability of the formulation. 
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Table 4.12 Staphylococcus aureus count after treatment 
 
  
Treatments 
Staphylococcus 
aureus 
(cfu/mL) 
Formulation 1 (with tannin fraction) 9.5 x 103  
Formulation 1 placebo 4.4 x 104 
Burnol® 3.4 x 103 
Without treatment 2.1 x 104 
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Figure 4.22 (a). Treatment results at Day 4 after inoculation of bacteria. (a) Formulation 1, (b) Placebo, (c) Burnol ® and (d) 
No treatment. 
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Figure 4.22 (b). Treatment results at Day 6 after inoculation of bacteria. (a) Formulation 1, (b) Placebo, (c) Burnol ® and (d) 
No treatment. 
  
194 
 
Figure 4.22 (c). Treatment results at Day 10 after inoculation of bacteria. (a) Formulation 1, (b) Placebo, (c) Burnol® and (d) 
No treatment. 
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CHAPTER 5 
DISCUSSION 
_______________________________________________________________ 
 
The significance and importance of natural product as a source of drug 
discovery is highlighted with the increasing rate of introduction of new 
chemical compounds as possible drug candidates and as templates for synthetic 
compounds, the number of diseases that is treated and prevented by natural 
products, as well as the frequency of it being use in treatment (Rout et al., 
2009). The approach of selecting plants for investigation for drug discovery 
through ethnopharmacological claims remain one of the most frequently used 
approach than random selection (Rout et al., 2009). In this research, we have 
selected our plant with the foundation of its ethnopharmacological claims as 
well as previous research findings, and proceed with more depth and strategy 
on gaining increased knowledge in natural product as a source of drug 
discovery. 
 
5.1  Acalypha wilkesiana var. macafeana hort. (Euphorbiaceae Juss.) 
 
Acalypha wilkesiana var. macafeana hort. (Euphorbiaceae Juss.) was selected 
for study due to its abundance in distribution in Malaysia and other tropical 
countries and the fact that it is seasonal all year round. This plant is also used 
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as an ornament. Despite the ethnopharmacological claim that sets the 
foundation of selection for this plant, it also has published results which 
complement its traditional uses. We set upon the research to investigate in 
more depth on the potential possibility of this plant as an antioxidant and 
antimicrobial agent. 
 
Several lines of evidence point to the fact that members of the genus Acalypha 
L. elicit several biological properties such as antioxidant (Badami & 
Channabasavaraj, 2007; Iniaghe et al., 2008), antimicrobial (Jebakumar et al., 
2005; Mothana et al., 2008), and anticancer (Madlener et al., 2010; Shin et al., 
2012). Several species in this genus have been tested clinically (Oyelami et al., 
2003). In all of the research aforementioned, phytochemical studies show that 
these properties are due to the secondary metabolites that are in abundant in 
this species such as terpenes, flavonoids and tannins (Amakura et al., 1999; 
Adesina et al., 2000). Understanding the background of a certain plant genus 
and species provides some lead to natural product study. Literature review is 
essential in setting the template of research although some scientists prefer 
random selection of plants.  
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5.2 Extraction of the Bioactive Secondary Metabolites from the Plant 
 
Extraction of natural product is crucial, considering that this is the first step in 
gaining the bioactive constituents from the plant of interest. Choosing a solvent 
for extraction is important as the solvent has to be able to extract constituents 
in interest of the study, or extract out as much compounds as possible, 
depending on the objective of the research (Ghisalberti 2008). The more 
efficient the extraction step, the greater the range of compounds present in the 
extract (Ghisalberti 2008). In this research we extracted air-dried material of 
the plant with sequential maceration from low to high polarity of solvent. 
Sequential extraction has been proved to give higher yield than using single 
solvents (Bazykina et al., 2002; Walia et al., 2011). This also provides a rough 
layout for screening of the crude extract for biological properties as it separates 
low polarity to higher polarity compounds.  For an example, ethanol extracts 
out polar, water-soluble compounds as hexane extracts out non-polar 
compounds and fatty acids (Bazykina et al., 2002; Ghisalberti 2008). 
Extraction with water might extract out saponins and glycosides (Kalaivani & 
Mathew 2009). 
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5.3  Biological Evaluations of the Crude Extract and Fractionation 
 
Screening of the antioxidant and antimicrobial properties of the crude extracts 
of A. wilkesiana var. macafeana hort. both evidenced that the ethanol extract 
gives the highest results for both biological activities. The hexane fraction did 
not exhibit any antibacterial properties against any bacterial strains tested. 
Hence, fractionation was executed on the ethanol extract to further locate the 
bioactive compound. Extraction with ethanol usually pulls out highly polar, 
water-soluble compounds such as aromatic phenolics, flavonoids, catechols, 
glycosides and tannins (Bazykina et al., 2002).  
 
Fractionation was commenced by an open column chromatography with 
Sephadex LH-20. Sephadex LH-20 is a crosslinked dextran gel that has both 
lipophilic and hydrophilic properties owing to the isopropyl groups of the 
hydroxypropylation and hydroxyl functions present (Henke 1995). The 
exclusion limit of Sephadex LH-20 at maximum swelling i.e., in 
dimethylsulfoxide (DMSO) is 4000, which means, all compounds with a 
molecular mass of more than 4000 elutes without separation as it only passes 
through the interparticle spaces (Henke 1995). Other compounds elutes in 
decreasing molecular size. Besides size exclusion, Sephadex LH-20 can also 
be used for adsorption chromatography (Henke 1995). 
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Our fractionation method used water/ethanol and water/acetone composition to 
take advantage of both exclusion characteristics of the gel and also the 
adsorptive separation (Henke 1995). Fraction 1 to fraction 4 were eluted out 
with water/ethanol mixtures in account to size exclusion, whereby the last 
fraction (F5) was eluted out with water/acetone by adsorptive separation as it 
was retained in the gel with water/ethanol mixture. Sephadex LH-20 sorbs 
tannins in alcohol and releases them with acetone. Hence, water/acetone 
mixtures were used to elute out tannins that are retained by Sephadex LH-20 
(Hagerman 2002). According to the Tannin Handbook of Hagerman (2002), 
Sephadex LH-20 is very useful in separating tannin to non-tannin phenolics.  
 
5.4  Antioxidant Properties of Fractions from the Ethanol Extract 
 
As part of an ongoing study in the Natural Product Team of our faculty to 
identify antioxidants from Asian medicinal plants (Wijaya et al., 2011a; 
Wijaya et al., 2011b), we have previously isolated flavonoid glucosides, 
flavanones and pyrrolizidine alkaloids. One of the largest groups of flowering 
plants is the family Euphorbiaceae Juss. which encompasses about 300 genera 
and 7500 species (Wiart 2006) of which many are considered as medicinal 
plants. In this context, it is worth to acknowledge that illnesses linked to 
oxidative stress are traditionally treated by members of the genus Acalypha L. 
such as Acalypha racemosa Wall. ex Baill., Acalypha indica Linn. and 
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Acalypha ornata Houchst. Ex A. Rich. thus these species have attracted the 
attention of researchers (Iniaghe et al., 2008; Kavitha et al., 2009; Joy et al., 
2010; Onocha et al., 2011; Mathew et al., 2011).  The notion of Acalypha L. 
alleviating illnesses induced by oxidative stress is further supported by an 
analysis of an unidentified species used to treat breast cancer and inflammation 
(Bussing et al., 1999; Lim et al., 2011). However, little attention has been 
focused on the antioxidant properties of members of the vast genus Acalypha 
L. 
 
With this premise in mind we have examined the antioxidant potencies of the 
Malaysian medicinal shrub Acalypha wilkesiana var. macafeana hort used to 
heal wounds, skin disorders and infections. To examine the antioxidant effects 
of Acalypha wilkesiana var. macafeana hort., we tested an ethanol extract 
using a panel of conventional tests which evidenced significant antioxidant and 
cytoprotective capacities. In order to identify the antioxidant principle, five 
fractions (F1-F5) from the ethanol extract were tested and F5 displayed robust 
antioxidant and cytoprotective effects. In natural product research, it is a 
practice to compare results of the active fraction(s) with the crude extract 
which it is was extracted out. This practice is important to observe whether the 
active fraction is really more potent than the crude extract or otherwise. In 
some instances, a single compound isolated out gives a less potent activity due 
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to synergy of more than one compound in the extract. Thus, comparison on 
crude with the isolated active fraction or compound is crucial to make sure the 
research is on track and not misleading. 
 
Several in vitro antioxidant techniques have been developed such as FRAP, 
DPPH and BCB assays. Indeed, one ought to perform several methods to 
accurately estimate the antioxidant potential of a sample as it should cover the 
mechanisms of different reactions (Huang et al., 2005). Recently, Moon and 
Shibamoto (2009) suggested combining assays associated with lipid 
peroxidations and assays associated with radical and electron scavenging in 
order to evaluate antioxidant capacity. In line with this contention, we analyzed 
our samples with three different assays to accommodate different antioxidant 
mechanisms.  
 
In order to evaluate the antioxidant potential of the ethanol extract of Acalypha 
wilkesiana var. macafeana hort. and its fractions, three antioxidant tests were 
performed; the FRAP assay, the DPPH rDGLFDO VFDYHQJLQJ DVVD\ DQG WKH ȕ-
carotene bleaching assay. The total phenolic content of the samples was also 
assessed using the Folin-Ciocalteau reagent. Interestingly, F5 displayed the 
most prominent antioxidant effect in all three assays as compared to other 
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fractions and the crude ethanol extract. The total phenolic content for F1 and 
F5 were significantly higher than the ethanol extract. Clear correlation is seen 
between the antioxidant potentials and the total phenolic content, thus 
suggesting that the phenolics account for antioxidant activity of the plant.  
 
Several studies have shown that the mechanism underlying polar antioxidant 
involves reactions with the hydroxyl (OH) group present in phenolics (Duthie 
& Crozier 2000). Indeed, phenolics are composed of one or more aromatic 
rings bearing one or more hydroxyl groups and are therefore potentially able to 
quench free radicals by forming stabilized phenoxyl radicals (Tang et al., 
2004) and most of the current antioxidants isolated so far from flowering 
plants are simple phenolic compounds which owe their properties to the mere 
fact that their aromatic hydroxyl moieties react with free radicals (Tang et al., 
2004).  
 
Given the involvement of hydroxyl (OH) groups, it is tempting to speculate 
that the total content of phenolic compounds could be seen as a standard step 
in the evaluation of antioxidant activities of plant extract. Indeed antioxidant 
capacities correlated with total phenolic content and DPPH reducing ability, in 
a study of traditional Chinese medicines (Dudonne et al., 2009). A comparative 
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antioxidant study of 30 plant extracts used in the nutraceutical industry 
highlighted a relationship between phenolics concentration in the plant extracts 
and their free radical scavenging and ferric reducing capacities (Hagerman et 
al., 1998).  
 
5.5  Antimicrobial Properties of Fractions from the Ethanol Extract 
 
According to Asian Network for Surveillance of Resistant Pathogens 
(ANSORP), MRSA infections accounts for 25.5 % of community-associated 
infections and 67.4 % of healthcare-associated infections in Asian countries 
(Song et al., 2011). In Malaysia, the annual MRSA infection rates ranged from 
5.0 to 19.5 admissions for every 1000 admissions (Al-Talib et al., 2010). 
Therefore, the increasing ability of pathogenic bacteria to develop resistance to 
DQWLELRWLFV MXVWLI\ WKH VHDUFK IRU ³FR-DQWLELRWLFV´ ZKLFK FRXOG EH YHU\ ZHOO
originated from natural products of plant origin. 
 
So the question arises on the significance of investing time and funds into 
characterizing antimicrobial substances from plants. Though the strengths of 
phytochemicals are less obvious, but it is certainly compelling due to four main 
reasons highlighted by Gibbons (2008). Firstly, their existence in plants for the 
very reason as a defense mechanism against soil and environment pathogens, 
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may very well be used against many Gram-positives and Gram-negatives 
bacterium. Secondly, in terms of phytotheraphy, there are countless examples 
of plants being used either systemically or topically to treat bacterial 
infections. There have to be opportunities to investigate antibacterial of plant 
origin. Thirdly, nDWXUH¶V H[WHQVLYH SRRO RI ELRDFWLYHV ZLWK XOWLPDWH FKHPLFDO
diversity which includes chiral structures and diverse functional groups 
engineered by the plants and last, the uniqueness of the phytochemical 
structure which are structurally different from microbial derived antibiotics 
might give a distinct mode of action from these existing compounds. All these 
arguments make strong points for researchers to continue to explore the field.  
 
Pour plate disc diffusion assay is one of the methods to quantify the 
antimicrobial activity of a substance based on the size of inhibition zone. The 
pour plate disc diffusion method is appropriate for screening of antimicrobial 
activity due to the possibility of testing few samples against a single 
microorganism, and the advantage of small quantity of sample needed (Rios et 
al., 1988). According to Gislene et al., (2000), any chemical that demonstrates 
zones of inhibition of more than 7 mm are acceptable as an active 
antimicrobial agent. In our research, most of the crude and fractions showed 
inhibition zones of more than 7 mm against Gram-positive bacteria tested, with 
F5 inhibiting more than 8 mm zone on all the strains tested. Crude extracts 
exhibits lower inhibition zone. This could be explained by slow diffusion of 
205 
large molecules into the agar and insufficient active compounds present in the 
crude extracts (Taylor et al., 2001). 
 
Though the pour plate disc diffusion method is a reliable method for screening 
preliminary antimicrobial compounds, it should never be used as a definitive 
method. Results of inhibition zones ought to be quantified with dilution assays 
(Rios et al., 1988). Dilution method involves homogenous dispersion of the 
sample in a microorganism selective culture media. Dilution method is 
necessary to determine the minimum inhibitory concentration (MIC) of 
compounds. Dilution assays are more laborious and requires more time, but it 
is often more precise. The dilution method is also the only method to identify 
the minimum bactericidal concentration (MBC) of a certain compound (Rios et 
al., 1988).  To avoid sedimentation of the plant extract during incubation, 
shaking throughout the experiment is required.   
 
Strong inhibitors have an MIC value lower than 500 µg/mL and moderate 
inhibitors are inhibitors with MIC value between 600 and 1500 µg/mL. 
Inhibitors with MIC value above 1600 µg/mL are recognized as weak 
inhibitors (Duarte et al., 2007; Wang et al., 2008). Pharmaceutical companies 
VHW D OHYHO RI DQ\ SK\WRFKHPLFDOV ZLWK 0,&¶V RI JUHDWHU WKDQ JP/ DV
SRRUO\DFWLYHDQGDUHLQWHUHVWHGLQSXUHSK\WRFKHPLFDOVZLWK0,&¶VRILGHDOO\
between 2 to 10 µg/mL (Gibbons 2008). In our study, we observed that the 
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fraction F5 inhibits Staphylococcus aureus and MRSA at 750 µg/mL, thus 
categorizes F5 as a moderate inhibitor. F5 kills both Staphylococcus aureus 
and MRSA at 3000 µg/mL. This is interesting as F5 still consists of more than 
one compound and is not a pure substance. It is compelling to suggest that F5 
might very well contain constituents which can exert strong inhibition against 
bacteria.  
 
This study highlights that neither the crude nor the fractions are good inhibitors 
of Gram-negative bacteria. This was to be explained by the structure of Gram-
negative bacteria. Gram-negative bacteria offer a more complex barrier system 
against permeation of foreign substances, in this case, the antimicrobial agents. 
This is attributed to the specialized cell wall structure and especially the 
presence of an outer envelope, which results impermeability of the bacterium 
against antibiotics (Denyer & Maillard 2002). 
 
5.6  Identification of Constituents of F5 
 
To gain further insights to the nature of active constituents of F5, high-
performance liquid chromatography (HPLC) and liquid chromatography ± 
mass spectrometry (LC-MS) analysis were performed allowing the 
identification of tannins. HPLC is an invaluable tool for analyzing natural 
products. Recent development of HPLC with small size column packings has 
207 
led to separation of compounds of closely related structures. Characterization 
and identification of tannins has been challenging due to the complexity, 
diversity and the large size of compounds. Multiple isomers of tannins can be 
present in one extract, thus creating more challenge in isolation of tannins.  
 
In our study the most challenging obstacle was to obtain a good separation of 
all the compounds in F5 due to the complexity and diversity of tannins. Some 
hydrolysable tannins are observed to form multiple peaks in reversed phase 
HPLC analysis, thus making it more challenging to separate the compounds 
(Hatano et al., 1988). The multiple peaks are due to the molecule of 
dehydrohexahydroxy-diphenoyl (DHHDP) that are present in ellagitannins 
which forms an equilibrium mixture of isomeric hydrated hemiacetals (Hatano 
et al., 1988). This mixture exhibits several peaks due to components which are 
isomeric and are retained differently in the column (Hatano et al., 1988).  
 
We also faced a challenge with optimizing a suitable solvent for HPLC 
analysis of the tannin fraction. Our observation is congruent with the findings 
of Hatano and colleagues (1988), as tannins which are dissolved in alcohol 
prior HPLC analysis, have remarkable changes in terms of peak shape and 
intensity in a time-dependant manner. We dissolved the sample in acetonitrile 
and prepared fresh samples to be used in the analysis for obtaining a standard 
chromatography profile of the tannin fraction. The wavelengths that are used 
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for detection of the compounds in the sample also have to be optimized in 
order to detect all of the compounds contained in the sample. As different 
wavelengths, detects different chromophores of a compound. In this research 
we opt to use 254 nm and 280 nm as it detected most peaks from the fraction. 
Both of these wavelengths detect chromophores of phenolics and tannins. 
Although these wavelengths detected the most compounds present in the 
fraction, there might be other compounds that are not visible with a UV/Vis 
detector, which are compounds that illuminates and are unable to be detected.  
 
With current chromatography technology, separations of tannins are 
achievable, though isolation and identification of the compound is still a 
challenge. The requirement of an amount of sample for identification via 
Nuclear Magnetic Resonance (NMR) is sometimes unattainable due to the 
large molecular mass of tannins. Hence, a large mass of sample is needed in a 
purity that is acceptable for analysis of NMR. Liquid Chromatography - Mass 
Spectrometry (LC-MS) then play a vital role in identification of tannins. The 
main advantage of this technology is its requirement of a very small amount of 
sample, and the possibility of identifying the compounds without isolation. 
 
LC-MS is recognized as a breakthrough in analysis and characterization of 
natural products with the synergy of both LC and MS. LC presents MS with 
cleaner samples, whereas MS helps reduce laborious sample preparation that 
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are usually required for analyte identification (Cheng et al., 2008). The 
combination of both of these powerful technologies makes it capable for 
accomplishing delicate and difficult separation and can be used to detect 
analytes with selectivity and sensitivity.  
 
In this study, we used soft ionization method, electrospray ionization (ESI) in 
negative mode and Time-of-Flight (TOF) analyzer. ESI is atmospheric 
ionization process which causes deprotonation or protonation of analyte 
molecules to generate even-electron charged species which are much stable 
against further fragmentation. Ionization in the negative mode produce 
deprotonated molecule [M-H]-, [M-H]2- or [2M-H]- ions (Salminen et al., 
1999). TOF is the current analyzer which accelerates ions generated using a 
high voltage along a vacuumed tube. In the accelerator, small ions would move 
faster compared to larger mass, thus arrives at different times depending on 
their m/z. The TOF analyzer has no mass limit range, thus it is suitable for 
analyzing high molecular weight compounds such as tannins.  
 
The major tannin was identified as geraniin. Geraniin is the main tannin of 
plants of the Euphorbiaceae family (Okuda et al., 1982). It forms an 
equilibrium mixture of a hydrated five-membered hemiacetal ring structure and 
a hydrated six-membered hemiacetal-ring upon mutarotation (Okuda et al., 
1982). Other compounds present in )DUHȕ-glucogallin (a simple gallotannin), 
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3 identified ellagitannins (Geraniin, potentillin and sanguiin H-6). Compounds 
are possible to be identified using LCMS due to the characteristic fragments 
that is obtained during ionization of the compound. Fragmentation of tannins 
with soft ionization method will lead to loss of common fragments as 
highlighted in many research. Loss of common fragments of tannins include 
152 a.m.u for loss of galloyl group, 301 for loss of hexahydroxydiphenoyl 
(HHDP) group, and 308 for loss of hexose-rhamnose sugar moiety (Salminen 
et al., 1999; Mullen et al., 2003; Seeram et al., 2006). Key fragments observed 
for tannins from LCMS analysis are fragments of m/z 633 and 301 in negative 
mode (Seeram et al., 2006; McDougall et al., 2008).  
 
Confirmation of the presence of ellagitannins is upon further fragmentation of 
the fragment m/z 301, which results to daughter fragments of m/z 229 and m/z 
257 (Mammela et al., 2000; Mullen et al., 2003; Seeram et al., 2006; 
McDougall et al., 2008).  LC-MS/MS method was needed to distinguish 
between the presence of quercetin or ellagic acid as both compounds produce 
molecular ions of [M-H]- m/z 301 (Mullen et al., 2003). MS/MS analysis 
showed that further fragmentation of m/z 301 yielded characteristic daughter 
ions of m/z 257 and 229 which is the unique pattern for ellagic acid (Seeram et 
al., 2006).  
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In our result, Compound (7) showed a m/z 935.0 which was shown to be 
doubly charged [M-2H]2- by zoom scan analysis giving its real m/z as 1870 for 
the peak as referenced in Hager et al. (2008) as sanguiin H-6 or lambertianin 
A. Zoom scan analysis is required to determine the charge state on an ion 
produced. Zoom scan data are collected using slower scans in a narrow mass 
range, which then improves the resolution of an analyte. This is an important 
tool to facilitate the correct molecular weight determination. The doubly 
charged deprotonated ion shows half of the m/z value for the parent ion. 
Doubly charged ions can be recognized by the isotopic distribution of 0.5 m/z 
unit separation between peaks as presented in Result. This is a common 
observation in analysis of large molecular weight compounds especially 
tannins (Mullen et al., 2003; Hager et al., 2008).  
 
Identification of the major compound, tentatively identified as geraniin by LC-
MS analysis, was then collected with a fraction collector and analyzed with 
NMR. Analysis with NMR is required for definitive identification of a 
compound. Though it is necessary, the setback of this analysis that it requires a 
high purity sample at a large amount especially for high molecular sample as 
tannins. We were only able to isolate the major compound as attempts for 
isolation of all the other minor compounds in F5 did not result in adequate 
sample for NMR analysis in terms of quantity and purity.  NMR analysis of the 
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isolated major compound provided us with a complicated spectrum as the 
signals were shown for both of the isomers of the hemiacetals of the DHHDP 
of geraniin. We then compared our shifts with shifts from previous literature. 
The comparison evidenced that the major compound is geraniin, as identified 
by LC-MS. Some of our observed shifts are showing a slightly different shift 
compared to the reference shift obtained from other journals. This is due to the 
purity of geraniin that was isolated. Although all parameters while collecting 
the sample are controlled to obtain the best purity of geraniin for NMR 
analysis, but it still does not give 100 % purity. Other compounds might still be 
contained in the sample for NMR analysis, thus shifting the ppm shifts of 
geraniin and shows a slight difference compared to the reference shift. 
 
Geraniin shifts are identified by dissolving geraniin with acetone and few 
drops of d20 (deuterated water) to provide equilibration of the two isomers. 
Upon equilibration, each carbon showed two peaks in the 13C spectrum in a 1:1 
ratio (Okuda et al., 1982). NMR has advantages in identification of tannins 
compounds as it provides direct information on stereochemistry and 
conformation of tannins, where as the disadvantage is the difficulty of 
interpretation of the spectra due to overlapping signals and broadening effects 
(Porter 1989).  
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The NMR spectra of hydrolysable tannins are identified to be divided to 3 
regions of resonances (Porter 1989): 
1) Resonances due to the D-glucose ring, which results in proton 
UHVRQDQFHEHWZHHQįDQGDQGFDUERQVVKLIWVLQWKHUDQJHRIį
to 97 
2) Shifts from the ring protons and carbons of the galloyl moiety which 
RFFXUVLQWKHįWRUDQJHIRUWKHSURWRQVDQGįWRIRUWKH
carbons 
3) Peaks resonate from carbonyl of the ester in tannins, show shifts that 
RFFXUEHWZHHQįWRIRUWKHcarbons. 
 
5.7  Tannins as the Bioactive Compounds in F5 of Acalypha wilkesiana 
var. macafeana hort. and Geraniin as the Major Compound. 
 
One of the groups of phenolic compounds is tannins, which were named for its 
WUDGLWLRQDOXVHRIµWDQQLQJ¶OHDWKHUE\FRnverting animal hides to leather. The 
ability of tannins to interact with proteins and precipitate it is its major 
characteristic. Tannins are also defined as water-soluble phenolic substance 
having molecular weights from 500 to 3000 and having a special property of 
ability to precipitate alkaloids, gelatin and other proteins. Most natural product 
214 
chemists define tannins to 2 classes which are hydURO\VDEOHWDQQLQV+7¶VDQG
FRQGHQVHGWDQQLQV&7¶VGHILQHGE\LWVPRQRPHU 
 
Environmental and geographical conditions play a role in the tannin 
composition of plants. These includes climate change, time of collection of the 
plants as well as storage conditions and drying conditions (Silva et al., 1998). 
Tannins sensu lato are present in woody plants such as Vitis vinifera L. 
(Vitaceae) and are extracted out with polar solvents such as water (Hagerman 
2002). In this research, we observed that the active fraction consists of 
K\GURO\]DEOH WDQQLQV  JDOORWDQQLQ ȕ-glucogallin) and 3 ellagitannin 
(potentillin, geraniin and sanguiin H-6). 
 
5.7.1 +\GURO\VDEOHWDQQLQV+7¶V 
x Gallotannins 
Hydrolysable tannins are derivatives of gallic acid (3, 4, 5-trihydroxyl benzoic 
acid). Gallic acid is (Figure 5.1) esterified to core polyol and the galloyl groups 
may be further crosslLQNHGWR\LHOGPRUHFRPSOH[+7¶V 
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Figure 5.1 . Gallic acid (3, 4, 5-trihydroxyl benzoic acid) 
 
 
 
Figure 5.2. Pentagalloyl glucose 
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Figure 5.3. Example of a depside bond which is formed between the phenolic 
group of the upper and the acid group of the lower gallic acid units. 
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7KHVLPSOHVW+7¶VDUHWKHJDOORWDQQLQVZKLFKDUHVLPSOHSRO\JDOOR\OHVWHUVRI
glucose. A typical gallotannin would be pentagalloyl glucose which has five 
identical ester linkages that involves aliphatic hydroxyl groups of the core 
sugars (Figure 5.3). Isomers of polygalloyl ester chains are formed by either 
meta- or para- depside bonds, involving a phenolic hydroxyl rather than an 
aliphatic hydroxyl group. The depside bond is more readily hydrolyzed than an 
aliphatic ester bond. 
 
x Ellagitannins 
Oxidative coupling of galloyl groups converts gallotannins to the related 
ellagitannins. Most simple elagitannins would be the esters of 
hexahydroxydiphenic acid (HHDP). HHDP spontaneously lactonizes to ellagic 
acid in aqueous solution (Figure 5.4). 
 
Ellagitannins can be defined as HHDP of carbohydrates or in a wider 
perspective would also cover compounds derived further from oxidative 
transformations including oligomerization process (Okuda et al., 2009). An 
important keystone in understanding ellagitannins is the isolation of geraniin 
from Geranium thunbergii which was one of the most popular medicinal plants 
used in Japan (Okuda 1982a).  
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Figure 5.4. HHDP spontaneously lactonizes to ellagic acid in an aqueous solution 
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Occurrence of ellagitannin in plants are often monomeric or oligomeric and is 
the main component of a plants species (Okuda et al., 2009). The 
pharmacological activity of the plants is sometimes attributable essentially to 
that component (Okuda et al., 2009). Intramolecular carbon-carbon coupling of 
HHDP is most common between C-4/C-6 and C-2/C-3, as it would be more 
stable in a 4C1 conformation. However, in some isolated compounds such as 
corilagin and geraniin, the intramolecular coupling occurs at C-3/C-6, 
suggesting that 1C4 is less stable. Geraniin is further characterized by partial 
oxidation of the C-2/C-4 HHDP to dehydro-HHDP in aqueous solution as 
detected by NMR (Hagerman 2002). 
 
5.7.2 Geraniin 
The major tannin in the antibiotic fraction F5 was identified as geraniin. 
Geraniin is present in many plants of the Euphorbiaceae family (Okuda et al., 
1982). It was first isolated from Geranium thunbergii Siebold ex Lindl. & 
Paxton, a Japanese medicinal plant used for antidiarrheic (Okuda et al., 1975). 
Geraniin forms an equilibrium mixture of a hydrated five-membered 
hemiacetal ring structure and a hydrated six-membered hemiacetal-ring upon 
mutarotation (Okuda et al,. 1982). In this context, it is of interest to note that 
the family Euphorbiaceae Juss. belongs to the superorder Rosanae Takht. like 
Geraniaceae Juss. thus, one could reasonably draw an inference that geraniin 
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may very well be a major active constituent in plants of the superorder 
Rosanae Takht.  
 
In fact, geraniin isolated from Geranium sibiricum L. (family Geraniaceae 
Juss.) exhibited the potent antioxidant activity together with corilagin and 
gallic acid (Ishimoto et al., 2012).  In a recent study of polyphenol metabolites 
conducted with the oxygen radical absorbance capacity (ORAC) assay, 
geraniin and its metabolites have shown potent antioxidant activity (Ling et al., 
2012). Additionally, geraniin has been found to posess apoptosis-inducing 
effects (Lee et al., 2008) and strong antioxidative properties in vitro (Agyare et 
al., 2009; Wu et al., 2010). 
 
Besides, geraniin has been described as an anti-inflammatory compound by 
inhibition of TNF Į-release and nitric oxide formation (Madlener et al., 2010; 
Kumaran & Karunakaran 2006). The latest finding has displayed geraniin as a 
cytoprotective agent against peroxynitrite generator 3-morpholinosydnonimine 
(SIN- DQG SHUR[\O UDGLFDO JHQHUDWRU ¶-azobis(2-amidinopropane) 
dihydrochloride (AAPH) in co-existence, suggesting that geraniin exhibits 
cytoprotective effects via free radical scavenging activity in the extracellular 
fluid (Ling et al., 2012). This study correlates the cytoprotective and 
antioxidant property of geraniin to its ortho-dihydroxy and galloyl groups 
present, as these groups are essential structures responsible for its electron 
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donating ability (Ling et al., 2012). A study on geraniin from Phyllanthus 
amarus recently exhibits that geraniin protects mouse liver from ethanol 
induced toxicity by inhibition of lipid and protein oxidation, and modulating 
Bax/Bcl2 ratio (Londhe et al., 2012).  
 
Geraniin from Phyllanthus muellerianus (Kuntze) Exell  is also identified as an 
effective wound healing agent as it is able to stimulate cellular activity, 
differentiation and collagen synthesis of human keratinocytes and dermal 
fibroblasts. This study isolated geraniin from Phyllanthus muellerianus 
(Kuntze) Exell (Agyare et al., 2011). The fact that geraniin possess antioxidant, 
cytoprotective and antibacterial properties, makes it a good candidate for an 
effective wound healing agent. An occurrence of wounds makes the skin 
exposed to external environment thus, makes it more prone to microbial attack 
and might delay the wound healing process (Pattanayak & Senita 2008). 
External application of antimicrobials to wounds prevents microbes invasion to 
the wound and protects it against infection (Pattanayak & Senita 2008). 
Research also points free radical scavenging action of antioxidants as one of 
the most important components of wound healing (Sen et al., 2002) and anti-
wrinkle products (Cho et al., 2007).   
 
Although geraniin is extensively suggested as a possible agent of antioxidant, 
antimicrobial, anti inflammatory and cancer therapy, it is observed that 
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geraniin are metabolized extensively in vivo with hydrolysis to ellagic acid in 
the small intestine being the first step (Zavala-Sanchez et al., 2011). This 
hydrolysis also occur in tissue culture medium, thus impose that any effects 
observed in cultured cellular systems may be due to geraniin or the released 
ellagic acid, or the combination of both. In vivo, geraniin and other 
ellagitannins are found to be hydrolyzed to corilagin, ellagic acid, gallic acid, 
brevifolin and brevifolin-carboxylic acid by gut microflora, with further 
metabolism to urolithins M1-M7 as presented in an excellent study by Ito and 
colleagues (Ito et al., 2007; Ito  2011). Whilst this evidence of metabolism of 
orally administered geraniin are relevant to in vivo administration, no evidence 
has yet been published that shows relevance of the same metabolism in other 
tissues. 
 
 5.8  Cytoprotection and Cytotoxic Evaluations of F5 (tannins) 
 
The potential cytoprotective effects of both the ethanol extract and F5 against 
cell death induced by t-BHP were evaluated in HepG2 cells. It can be 
concluded that both the ethanol extract and F5 were non-toxic alone in all the 
concentration tested (6.25 ± 100 µg/mL) and also protected the cells against 
cell death in a dose-dependent manner, with F5 being more potent than the 
ethanol extract. 
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The ability of antioxidants like ellagitannins or an extract to protect cells 
against oxidative insults are difficult to extrapolate only from in vitro chemical 
tests, thus in vitro cell culture evaluation is crucial to assess antioxidants that 
might be used in disease prevention and health promotion (Vidyashankar et al., 
2010). Cell culture models are used to investigate biological effects of 
antioxidants in vitro as animal or human models are expensive and labor 
extensive (Vidyashankar et al., 2010).  
 
HepG2 is wild-type p53 human hepatocellular carcinoma cell which is 
considered a good model to study in vitro toxicity and protection of the liver, 
as it retains many of the specialized functions of normal human hepatocytes 
(Park et al., 2010) including vulnerability to reactive oxygen species. t-BHP is 
an organic hydroperoxide which generate free radicals that initiate lipid 
peroxidation in HepG2, leakage of lactate dehydrogenase (LDH) and apoptosis 
(Yoo et al., 2008). In line with this contention, we measured protective effect 
of the ethanol extract and F5 against t-BHP-induced insults in HepG2 cells. 
The results obtained convincingly evidenced that F5 is cytoprotective. Since 
F5 consists of phenols, our results are in agreement with previous studies 
evidencing correlation between antioxidant capacities and cytoprotective 
effects (Zhang et al., 2006; Vidyashankar et al., 2010; Wu et al., 2010).  
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5.9  Synergistic properties of F5 (Tannin) and FESEM observation 
 
The antimicrobial properties of tannins have been well documented by Chung 
et al. (1998). Tannins have been reported to be bacteriostatic (Yoshida et al., 
2009) and bactericidal (Yoshida et al., 2009). Inhibitory effects of tannins are 
owed to the ester linkage between gallic acid and polyols (Chung et al., 1993). 
Scalbert (1991) summarizes the mechanism of antimicrobial action of tannins 
as follow: 
1. Astringent character of tannin induce complexation with enzymes or 
substrates 
2. Inhibition of electron transport system on the membranes of the 
microorganism 
3. Complexation by metal ions. 
 
The antimicrobial property of tannins might involve more than one mechanism 
above mentioned, though researches using purified tannins are still unsolved. 
In a review by Rios and Recio (2005), interactions with commercial antibiotics 
and mechanism of actions of natural antimicrobial compounds are the niche of 
future research that should be a more interest to researchers. 
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To date, evidence imply that the main mechanisms involved in tannin 
bacteriotoxicity is the inhibition of extracellular microbial enzymes, 
deprivation of nutrients, direct action on bacterial metabolism through 
inhibition of oxidative phosphorylation and metal ion chelation (Scalbert 
1991). Ellagitannins are able to precipitate protein and remove metal cofactors 
through their strong affinity for metal ions, thus acting as microbial barrier 
(Daglia 2012).  
 
As part of the continuous effort to identify antibiotic from medicinal plants 
(Wiart 2000, Wiart 2006a, Wiart 2006b, Wiart 2010), we found that A. 
wilkesiana var. macafeana hort. produces tannins (F5) which are bactericidal 
against MRSA. Synergistic studies were done to have a picture on the 
mechanism of action of the tannins and observe the potential of F5 to 
potentiate antibiotics activity. We opt to use 3 different antibiotics with 2 
different mechanisms of action, which are ampicillin (inhibitor of cell wall 
synthesis), and tetracycline and streptomycin (inhibitors of protein synthesis). 
Our study demonstrates that ellagitannins from the medicinal A. wilkesiana 
var. macafeana hort. (F5) acts synergistically with ampicillin.  
 
$PSLFLOOLQLVDȕ-lactam antibiotic that functions by covalently combining with 
penicillin binding proteins (PBPs) and inactivating transpeptidases which are 
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responsible for the peptidoglycan cell wall synthesis (Zhao et al., 2001). 
Ampicillin was discovered in 1961 shortly after scientists from Beecham 
Research Laboratories found 6-aminopenicillanic acid (Rolinson & Geddes 
2007). Resistance to ampicillin was soon reported in 1987, 26 years after it is 
introduced (Boyce et al., 1992). Currently, 100 % of Enterococcus faecium 
isolates are resistant to ampicillin in the United States (Arias & Murray 2009), 
though ampicillin is still prescribed for other Gram-positive infections. Search 
for natural product compounds which can be combined with an antibiotic for 
treatment of drug resistant bacteria are an important alternative to overcome 
bacterial resistance (Sibanda & Okoh 2010). 
 
Studies have also unveiled the effect of polyphenolic compounds against 
methicillin-resistant Staphylococcus aureus (MRSA), and some ellagitannins 
ZHUHIRXQGWRSRWHQWLDWHDQWLEDFWHULDOHIIHFWRIȕ-lactam antibiotics (Yoshida et 
al., 2009). ,QDVWXG\E\6KLRWDHWDOWKH0,&¶VRIR[DFLOOLQDȕ-lactam 
antibiotic, was decreased noticeably in presence of epicathechin gallate (ECG). 
A continuous study then observed that the effect of combining oxacillin and 
ECG was bactericidal against MRSA (Shiota et al., 2000). Likewise, a study of 
V\QHUJLVWLFHIIHFWRIFRULODJLQDQGR[DFLOOLQDOVRH[KLELWHGUHGXFWLRQRI0,&¶V
of MRSA with the combination (Shimizu et al., 2001).  
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Resistance of antibiotics in MRSA is due to the production of penicillin 
ELQGLQJSURWHLQD3%3DZKLFKLQDFWLYDWHVȕ-lactamase in the bacteria. The 
tannins were found to decrease the production of PBP 2a, inactivate PBP 2a 
DQGVXSSUHVVWKHȕ-lactamase activity (Shiota et al., 2000). A series of research 
about compounds with synergistic ability with antibiotic, revealed that 
ellagitannins and condensed tannins are effective agents that reduces resistance 
of MRSA (Yoshida et al., 2009). The effect against the antibiotic resistance, 
whether it is bacteriostatic or bactericidal were found to be dependent on the 
polyphenolic structure (Yoshida et al., 2009).  
 
To illustrate surface morphology of the bacterial cell wall upon treatment with 
the samples, FESEM analysis were performed on Staphylococcus aureus 
(ATCC 11632) and MRSA. The control cells without any treatments were full 
and smooth on the surfaces, as cell walls are undisrupted and well formed. 
Treatments with the MIC dose of the ethanol extract (1500 µg/mL) disrupted 
the cell wall integrity of S. aureus as surface deformation was observed. 
MRSA cells were observed adhered to each other with biofilm forming on the 
cells suggesting that some amounts of intracellular materials are released as 
observed in Li et al. (2011). Total collapse and broken cells were observed 
with the treatment with MIC dose of F5 on both S. aureus (ATCC 11632) and 
MRSA, as cell debris and indentation of the cell surface were seen. This 
suggests total lysis of the bacteria leading to bacterial death. 
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5.9 Formulation of F5 and in vivo animal study 
 
Formulation 1 consisted of 60 % water with a white soft paraffin and liquid 
paraffin base. Nature of base in which a drug is formulated has considerable 
effect on its efficacy and safety, thus experimenting with different excipients is 
extremely an important step in a formulation (Pifferi & Restani, 2003). 
Paraffin-water based formulation forms a hydrophobic base cream which 
provides an emollient effect and preferred for most end users as it is easier to 
apply and remove and more elegant by appearance and post application 
(Kanaujia et al., 2008). 
 
The efficacy of the active tannin compounds in the formulation was observed 
as the test was repeated until day 10 after the formulation was prepared. 
Stability of the active compound in the excipients is an important parameter in 
formulation (Ordoñez et al., 2009). Excipients of choice have to support the 
active compound as in not oxidizing it or interacting with it in such a way that 
the efficiency of the active compound is compromised (Pifferi & Restani 
2003). Stability of the active compound has to be within the recovery period of 
an illness so that the cream will be effective for a specific treatment (Ordoñez 
et al., 2009). 
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The ability of the active ingredient to inhibit skin against infections depends on 
an appropriate formulation that can maintain the integrity of the active 
compound and deliver it in a biological active form to the infected site 
(Ordoñez et al., 2009). It also has to reach the target site in sufficient quantity 
to be able to exert and effect and properly release bioactive substance from the 
carrier vehicle (Ordoñez et al., 2009). Formulation 2 (wool fat cream base) and 
Formulation3 (liquid paraffin base) are unable to exert the antibacterial 
property wanted. This is due to the bases unable to either maintain the integrity 
of the tannins or unable to deliver the active compound in an active form in 
sufficient quantity. 
 
Plant derived antibacterials also have a huge potential of being a topical 
material rather than systemic drugs and there is currently a need for new 
compounds of topical agents to replace current ones like fusidic acid and 
mupirocin where resistance have been exhibited in some instances (Gibbons 
2008). Advantages considered for topical route over the systemic would 
particularly be the speed to market and the amount of clinical data to be 
approved (Gibbons 2008). 
 
To further assess the effectiveness of Formulation 1 against Staphylococcus 
aureus infections, the formulation (dose) was tested in vivo on guinea pigs that 
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were infected with the aforementioned bacterium. It was observed that 
Formulation 1 promoted effective wound healing property than Burnol® as the 
wounds closed and healed 4 days faster, suggesting that tannins are critical in 
this instance. This would suggest that the antioxidant property of the 
formulation plays a role in the wound healing ability of the formulation. As for 
the antibacterial property of the formulation, it was not observed as the 
infections did not produce symptoms as predicted such as abscess and 
inflammation of the wound. This would be justified as the guinea pigs used are 
normal guinea pigs which have their immune defence system, that 
automatically prevents infections of the wounds. We would suggest future 
studies undergo the study with immune compromised guinea pigs in order to 
obtain the symptoms of the infections before treatment. 
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CHAPTER 6 
CONCLUSION 
_______________________________________________________________ 
 
Acalypha wilkesiana var. macafeana hort. was selected for the study based on 
its pharmacological and ethnomedicinal claims. The plant is also abundant in 
Malaysia, as it is an easily grown ornamental plant in tropical countries. A. 
wilkesiana var. macafeana hort. is identified as a traditional treatment for skin 
infections, wounds, inflammation and cancer, which relates to its antioxidant, 
antibacterial and cytoprotection properties that we have observed in our 
research.   
 
Screening of the antioxidant property of the plant was assessed with Ferric 
reducing antioxidant power (FRAP) assay, ȕ-carotene bleaching assay and 2,2-
diphenyl-1-picryl-hyrdrazyl (DPPH) assay, where as the antibacterial property 
of the plant was tested with the pour plate disc diffusion assay. In all of the 
methods tested, the ethanol extract was the most active extract in both 
antioxidant and antibacterial assays. In view of the potential of this plant for 
discovery of new antioxidant and antibacterial agent for tropical countries, 
fractionation was commenced on the ethanol extract via chromatography 
affording 5 fractions. After all fractions were tested with the same assay as the 
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extracts, results showed that F5 was the most active fraction and warrants 
further study. 
 
To shed light on the active constituents of F5, identification was done with 
high performance liquid chromatography (HPLC), liquid chromatography 
mass spectrometry (LCMS) and nuclear magnetic resonance (NMR). 
Separation was obtained with reversed phase HPLC which showed one major 
compound and 6 minor compounds. The major compound was collected with a 
fraction collector and identified as Geraniin via interpretation and comparison 
of its NMR shifts, while the other 3 compounds were identified by 
fragmentations of LC-MS. The compounds identified are ȕ-glucogallin, 
potentillin and sanguiin H-6. All identified compounds are ellagitannins, 
except for ȕ-glucogallin which is a gallotannin. Three other compounds were 
unidentified ellagitannins without any similar fragmentation from literature.  
 
Environment and geographical conditions plays a role in the tannin 
composition of plants. This includes climate change, time of collection, as well 
as storage and drying conditions. Tannins sensu lato are present in woody 
plants and are extracted out with polar solvents such as ethanol and water. 
Characterization and identification of tannins has been a challenging task due 
to the complexity, diversity and the large size of the compounds. Existence of 
multiple isomers of tannins present adds on to the challenge. With 
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identification of the constituents of F5, we understand that the antioxidant and 
antibacterial property it elicits are due to these hydrolysable tannins.  
 
The ability of antioxidants like ellagitannins to protect cells against oxidative 
insults are difficult to extrapolate only from in vitro assays, thus in vitro cell 
culture evaluation were done to assess the cytoprotective and cytotoxicity of 
F5. The cell based assay was performed to HepG2 cells and F5 were observed 
able to protect cells against cell death induced by t-BHP insults in a dose-
dependent manner. F5 was also found non-toxic in the concentration needed to 
protect the cells, which is 100 µg/mL.  
 
We then explored the synergistic property of F5 with commercial antibiotics, 
as co-antibiotics are one of a new approach to overcome resistance of bacteria. 
We observed F5 from A. wilkesiana var. macafeana hort. and ampicillin inhibit 
the growth of Gram-positive bacterium synergistically. To observe the 
mechanism of action to the bacteria, specifically Staphylococcus aureus, Field 
Emission Scanning Electron Microscopy (FESEM) analysis was done. FESEM 
analysis is able to demonstrate the action of the antimicrobial agent to the 
bacterium surface morphology. The results that we obtained suggest that the 
bactericidal mechanism of F5 involves cell wall lysis as the result illustrates 
indentation of the cell surface and some showed total collapse of the cells. 
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The fact that F5 possess antioxidant, antimicrobial, and cytoprotective 
properties makes it a good candidate for an antimicrobial topical wound 
healing agent. This is explored by formulating three topical formulations 
containing F5, which were then tested in vitro against Staphylococcus aureus. 
Results pointed to formulation 1 being the effective formulation in vitro which 
consisted of water, white soft paraffin and liquid paraffin base. Nature of a 
base in which a drug is formulated plays a considerable effect on its efficiency 
and safety.  
 
To further assess the effectiveness of the formulation, in vivo animal study was 
done on guinea pigs with an incised cut infected with Staphylococcus aureus. 
Treatment with formulation 1, Burnol® and a placebo showed that the closure 
and healing of the wound was faster with treatment with Formulation 1 than 
Burnol®. Although this is very preliminary, the result indeed gives weight to 
the ability of F5 from A. wilkesiana var. macafeana hort. to heal infected 
wounds in accordance to its traditional use. 
 
Our results indicate possible use of ellagitannins from A. wilkesiana var. 
macafeana hort. with ampicillin to treat Staphylococcus aureus infections as it 
is bactericidal via a mechanism involving cell lysis. It also illustrates the 
possibility to be used as a topical wound healing agent with respect to its 
antibacterial and antioxidant properties. Taking into account its in vitro 
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bactericidal activity and the antioxidant property, the ellagitannins from A. 
wilkesiana var. macafeana hort. can be viewed as a new bactericidal agent that 
should contribute to the development of topical antibacterial drug or cosmetics 
or co-antibiotics in tropical countries. 
 
In summary, our work demonstrates for the first time that the antioxidant and 
antibacterial properties of the plant as used in Malaysia is owed to 
ellagitannins such as geraniin which not only aggravates the survival of Gram-
positive bacteria via cell lysis, it also fight oxidation and protect cells, thus 
making this Malay medicinal plant a first line candidate for the industrial 
pharmaceutical and cosmetic ointments for the tropical developing world.  
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CHAPTER 7 
RECOMMENDATION FOR FUTURE STUDIES 
_______________________________________________________________ 
 
The main purpose of this study was to contribute to the knowledge of plant 
species with therapeutic potential, especially in Malaysia where plants are 
being used in traditional medicines for various illnesses. Malaysia is a rich 
tropical country which encompasses of many unexplored flora. This research 
only covers one of the many other potential plants. Natural product research 
especially on obtaining justification to traditional uses and discovering new 
potential drug candidates should be continued. 
 
For this specific study, recommendations for further research are described as 
follow: 
x Identification of the minor compounds with NMR 
We have identified the constituents of the active tannin fraction, F5 with 
fragmentation via LC-MS. As this is not a definitive method for identification, 
the identification remains tentative. Large scale of separation with a 
preparative column via HPLC should be considered in isolating the minor 
compounds in the fraction. Although very challenging, overcoming this barrier 
would open many more opportunities to understand and evaluate the every 
single pure compounds, not as a fraction. This might portray synergy activity 
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or antagonist reaction from the entire compound in the fraction, and might lead 
to a better result.  
 
x Mass isolation of the major compound, Geraniin 
Further understanding on geraniin as an antioxidant, antibacterial and wound 
healing agent would be attainable with a higher quantity of geraniin isolated. 
In our attempt, we managed to isolate geraniin just enough for identification 
via NMR. Thus, an effective isolation method could be ventured maximizing 
quantity, with the pure quality of geraniin that can be use to evaluate its 
activity in depth. 
 
x Cytoprotection studies 
Geraniin potential influence on skin cells should be assessed to validate its 
wound healing properties with regards to its antioxidant and antibacterial 
property. Cytoprotection assay can be done on dermal fibroblasts or epithelial 
cells in in vitro cell culture conditions. This might show a better understanding 
on its effect regarding cell differentiation, and collagen synthesis that relates to 
wound healing and normal metabolism of the cells. 
 
x Geraniin as an antibacterial agent 
The antibacterial activity of the tannins in F5 was only determined with 3 
strains of Gram-positive bacteria, and was focussed on only Staphylococcus 
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aureus for further studies on its synergistic properties with antibiotics and 
SEM analysis of the surface morphology of the bacteria. We suggest that to 
emphasize on its ability as an antibacterial agents, tests can be performed with 
more Gram-positive bacteria other than Staphylococcus aureus. This would 
give a larger view and understanding of the synergistic properties, and the 
mechanism of action. Other commercial antibiotics with different mechanism 
of action should also be investigated for its synergy with the tannins such as 
with inhibitors of cell membrane synthesis (Polymixin B) and inhibitors of 
nucleic acid synthesis (Rifamycin). To make a strong case on its mechanism as 
an inhibitor of cell wall synthesis, synergy studies can also be performed on 
other inhibitors of cell wall such as Chloramphenicol. 
 
x Formulation of the active principle as a topical medication 
This study has highlighted preliminary results on the ability of the tannins from 
A. wilkesiana var. macafeana hort. to be formulated as a topical medication. 
We have determined the microbiological stability, as we tested its effectiveness 
against the bacteria for a certain period of time. Deeper stability studies are 
recommended such as physical stability evaluation, viscosity evaluation and 
pH measurements. Recommendation also for permeability studies of the 
formulation through a dermal model to validate its permeability to skin as a 
topical antioxidant and antibacterial agent. 
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x Wound healing formulation 
To dwell deeper in understanding the tannins from A. wilkesiana var. 
macafeana hort. as a wound healing agent, we recommend including more 
parameters and variables such as determining the wound contraction, tensile 
strength, and histopathological study on the wound tissues. This would 
illustrate an overall understanding n the wound healing mechanism of the 
tannins.  
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